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1. Introduction   1 
1. Introduction 
Over the last decade, the neuropeptide oxytocin (OXT) has received considerable 
attention for its crucial role in social behavior and social cognition (Adolphs, 2010; Ebstein, 
Israel, Chew, Zhong, & Knafo, 2010; Insel, 2010). Moreover, OXT has been regarded as a 
promising target for the treatment of mental disorders that are characterized by marked 
deficits in social behavior and social cognition (Meyer-Lindenberg, Domes, Kirsch, & 
Heinrichs, 2011), such as autism spectrum disorders (ASD), borderline personality disorder 
(BPD) or social anxiety disorder (SAD). Motivated by animal studies revealing dramatic 
effects of OXT on social anxiety, social stress and social recognition (Neumann, 2008), 
numerous studies have been conducted to investigate whether OXT has similar effects on 
social cognition and social behavior in humans (Meyer-Lindenberg, et al., 2011). 
Most of these studies were limited by methodical constraints inherent in human 
research. Whereas animal researchers were able to use non-invasive as well as invasive 
methods in their studies (e.g., central administration of OXT agonists and antagonists, 
manipulation of OXT and OXT receptor (OXT-R) expression by gene inactivation, 
assessment of OXT messenger RNA), researchers investigating OXT effects in humans had 
mainly to rely on non-invasive methods. One prominent method was to correlate markers of 
OXT activity in urine (e.g., Fries, Ziegler, Kurian, Jacoris, & Pollak, 2005), saliva (e.g., 
Feldman, Gordon, & Zagoory-Sharon, 2010) or blood (e.g., Zak, Kurzban, & Matzner, 2005) 
with changes in social behavior and social cognition. However, the relationship between 
peripheral and central OXT is not well understood (Landgraf & Neumann, 2004), leaving 
open whether changes in peripheral OXT levels indeed reflect changes in central OXT levels. 
In consideration of this, researchers used markers of OXT activity in cerebrospinal fluid 
(CSF) rather than in urine, saliva or plasma in their studies (e.g., Heim et al., 2009). However, 
assessing central OXT levels is much more invasive than assessing peripheral OXT levels, 
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rendering this method impracticable in many circumstances. In addition, this method also 
involves the use of correlation analysis, which precludes any inferences about the causality of 
the respective findings. To overcome these limitations, researchers used intravenous infusion 
(e.g., Hollander et al., 2003) or intranasal application (e.g., Kosfeld, Heinrichs, Zak, 
Fischbacher, & Fehr, 2005) of OXT to gain more insights into OXT effects on social 
cognition and social behavior. Since only a small fraction of OXT passes the blood-brain 
barrier after intravenous infusion (Kang & Park, 2000) as compared to intranasal application 
(Born et al., 2002; Chang, Barter, Ebitz, Watson, & Platt, 2012), intranasal application has 
become the method of choice for researchers investigating the social effects of OXT (Bartz, 
Zaki, Bolger, & Ochsner, 2011; Guastella & MacLeod, 2012). In addition, researchers 
genotyped polymorphisms of the OXT-R to elucidate the genetic mechanisms underlying 
OXT effects on social cognition and social behavior (Ebstein, Knafo, Mankuta, Chew, & Lai, 
2012), either alone (e.g., Chen et al., 2011) or in combination with intranasal application of 
OXT (e.g., Sauer, Montag, Worner, Kirsch, & Reuter, 2012).  
Up to now, studies employing the aforementioned methods have revealed striking 
similarities between OXT effects on social behavior and social cognition in animals and 
humans (Meyer-Lindenberg, et al., 2011). Most relevant here, OXT also facilitates social 
recognition (e.g., Domes, Heinrichs, Michel, Berger, & Herpertz, 2007; Fischer-Shofty, 
Shamay-Tsoory, Harari, & Levkovitz, 2010; Lischke, Berger, et al., 2012; Marsh, Yu, Pine, & 
Blair, 2010; Prehn et al., under review; Schulze et al., 2011) and social memory (e.g., 
Guastella, Mitchell, & Mathews, 2008; Rimmele, Hediger, Heinrichs, & Klaver, 2009; 
Savaskan, Ehrhardt, Schulz, Walter, & Schachinger, 2008) in humans, stressing the 
therapeutic potential of OXT for the treatment of individuals with impairments in social 
cognition. Notwithstanding these promising findings, it has to be acknowledged that the 
mechanisms underlying the social effects of OXT are poorly understood (Bartz, et al., 2011).  
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The present thesis provides a review of previous studies examining the effects of OXT 
on social cognition and describes a series of recent studies that were explicitly designed to test 
possible mechanisms accounting for OXT effects on social memory and social recognition1. 
The findings of these studies are discussed in the context of previous studies2, while 
considering implications for future studies investigating the therapeutic potential of OXT. 
1.1. Effects of oxytocin on social cognition 
1.1.1. Social recognition 
Domes and colleagues (Domes, Heinrichs, Michel, et al., 2007) performed the first 
study dealing with OXT effects on social recognition (see Table 1 for an overview of similar 
studies). Using a double-blind, placebo-controlled within-subjects design, they administered 
24 international units (IU) of OXT or placebo (PLC) to 30 males who participated in a well 
established social cognition task, the Reading the Mind in the Eyes Test (Baron-Cohen, 
Wheelwright, Hill, Raste, & Plumb, 2001). During task performance, participants had to infer 
complex emotional expressions from the eye region of 36 (18 male, 18 female) faces (self-
paced). OXT improved participants’ recognition accuracy, in particular for those expressions 
that were most difficult to recognize3. Since Domes and colleagues (Domes, Heinrichs,  
                                            
1 The focus of this thesis is on studies examining OXT effects on social recognition and social memory in male 
individuals. Only studies employing face processing tasks and intranasal OXT challenge are considered. 
Although this thesis primarily deals with OXT effects on social cognition in healthy individuals, studies 
examining these effects in mentally disordered individuals are also discussed if necessary. Of note, only studies 
that have been published prior to the 1st of May 2012 are included in the review. 
2 Since this thesis is based on the findings of three studies, a summary of the studies’ most important findings 
rather than a detailed account of each single finding is provided. For a detailed description of the studies’ 
findings, the reader is referred to the respective passages of the corresponding publications (see Appendix). 
3 Similar effects were reported in studies investigating OXT effects on social recognition in individuals 
exhibiting traits associated with mental disorders (Luminet, Grynberg, Ruzette, & Mikolajczak, 2011) as well as 
in individuals with mental disorders (Guastella et al., 2010). These findings indicate that OXT may, in fact, be 
useful for the treatment of individuals with deficits in social cognition and social behavior (Meyer-Lindenberg, 
et al., 2011). 
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Michel, et al., 2007) only examined whether OXT enhances the recognition of complex 
emotional expressions, such as desire or hate, Fisher-Shofty and colleagues (Fischer-Shofty, 
et al., 2010) investigated how OXT affects the recognition of basal emotional expressions, 
such as fear or anger. In a double-blind, placebo-controlled within-subjects design, 27 males 
received 24 IU of OXT or PLC before they viewed 36 (18 male, 18 female) eye regions of 
faces with dynamically changing expressions. Each face was initially presented with a neutral 
expression that subsequently turned into an emotional one (6 happy, 6 angry, 6 fearful, 6 
disgusted, 6 sad, 6 surprise; 100 ms per 1% increase in emotional intensity). Participants had 
to detect the onset of the developing expression and to identify the respective emotion. OXT 
specifically enhanced participants’ recognition accuracy for fearful expressions, while having 
no effect on their recognition sensitivity. That is, OXT improved participants’ ability to 
recognize fearful expressions, but did not change the threshold at which these expressions 
were recognized.  
The aforementioned studies revealed that OXT improves emotion recognition from the 
eye region of faces. However, beneficial effects of OXT on emotion recognition have also 
been reported during the processing of all facial regions as suggested by Di Simplicio and 
colleagues (Di Simplicio, Massey-Chase, Cowen, & Harmer, 2009) and Marsh and colleagues 
(Marsh, et al., 2010). In a double-blind, placebo-controlled between-subjects design, Di 
Simplicio and colleagues (Di Simplicio, et al., 2009) administered 24 IU of OXT or PLC to 
29 males who had to identify the expressions of briefly presented faces (500 ms). In total, 250 
(125 male, 125 female) faces showing various expressions (10 neutral, 40 happy, 40 angry, 40 
fearful, 40 disgusted, 40 sad, 40 surprised) at different intensity levels (ranging in emotional 
intensity from 0% to 100%) had to be analyzed by the participants. Although OXT had no 
effect on participants’ recognition accuracy, it attenuated the misclassification of positive 
(happy) or ambiguous (neutral, surprised) expressions as negative (angry, fearful, disgusted, 
1. Introduction   6 
sad) ones. Since the study suffered from various methodical limitations (Guastella & 
MacLeod, 2012; Marsh, et al., 2010), Marsh and colleagues (Marsh, et al., 2010) performed a 
similar study to replicate and extend these findings. In a double-blind, placebo-controlled 
between-subjects design, 29 males and 21 females received 24 IU of OXT or PLC before they 
viewed 360 (180 male, 180 female) faces expressing various emotions (60 happy, 60 angry, 
60 fearful, 60 disgusted, 60 sad, 60 surprised) at different intensity levels (ranging in 
emotional intensity from 0% to 100%). Following each face presentation (500 ms), 
participants had to identify the emotional expression of the respective face. In contrast to Di 
Simplicio and colleagues (Di Simplicio, et al., 2009), Marsh and colleagues (Marsh, et al., 
2010) revealed that OXT specifically enhanced participants’ recognition accuracy for happy 
expressions. Of note, there was no evidence indicating that OXT differentially affected 
recognition accuracy in males and females, ruling out that OXT exerted sex-specific effects 
on social cognition as recently suggested (Domes et al., 2010; Lischke, Gamer, et al., 2012a, 
2012b). 
1.1.2. Social memory 
The first study investigating OXT effects on social memory was performed by 
Guastella and colleagues (Guastella, Mitchell, & Mathews, 2008; see Table 2 for an overview 
of similar studies). Using a double-blind, placebo-controlled between-subjects design, they 
administered 24 IU of OXT or PLC to 69 males who had to provide trustworthiness and 
acceptance ratings for 36 faces (2 s) depicting neutral (6 male, 6 female), happy (6 male, 6 
female) or angry (6 male, 6 female) expressions. Twenty-four hr later, participants completed 
a surprise memory test, which required them to distinguish the 36 faces (self-paced) they had 
seen previously from 36 faces (12 neutral, 12 happy, 12 angry; self-paced) they had not seen 
previously on basis of “remember”, “know” and “new” judgments. OXT specifically 
enhanced participants’ memory for happy but not neutral or angry expressions in terms of  
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familiarity ratings. Although the findings by Guastella and colleagues indicated that OXT 
improves social memory (Guastella, Mitchell, & Mathews, 2008), it remained open whether 
OXT in fact facilitated social as compared to non-social memory. In consideration of this, 
Rimmele and colleagues (Rimmele, et al., 2009) examined how OXT affects memory for 
social and non-social stimuli. In a double-blind, placebo-controlled between-subjects design, 
44 males received 24 IU of OXT or PLC before they provided approach ratings for 84 faces 
(3.5 s) showing neutral (14 male, 14 female), positive (14 male, 14 female) or negative (14 
male, 14 female) expressions as well as for 84 images (3.5 s) depicting houses (21 images), 
objects (21 images) or landscapes (42 images). After 24 hr, participants had to complete a 
similar surprise memory test as the one administered by Guastella and colleagues (Guastella, 
Mitchell, & Mathews, 2008). By providing “remember”, “know” and “new” judgments, they 
had to distinguish the 84 faces (5 s) and 84 images (5 s) they had seen previously from 36 
faces (12 neutral, 12 positive, 12 negative; 5 s) and 36 images (9 houses, 9 objects, 18 
landscapes; 5 s) they had not seen previously. OXT specifically improved participants’ 
memory for faces in terms of familiarity ratings, while leaving these ratings for non-faces 
unaffected. Moreover, this face-specific memory effect was not restricted to a particular type 
of expression as reported by Guastella and colleagues (Guastella, Mitchell, & Mathews, 2008) 
but was present during the processing of all expressions, irrespective of the expressions’ 
emotional valence (neutral, positive, negative). 
Although the aforementioned studies revealed beneficial effects of OXT on social 
memory, these studies only investigated how OXT affects the encoding (Guastella, Mitchell, 
& Mathews, 2008; Rimmele, et al., 2009)4 but not the consolidation of facial expressions. To 
                                            
4 Although most studies showed that OXT improves the encoding of facial expressions (Guastella, Mitchell, & 
Mathews, 2008; Rimmele, et al., 2009), one study failed to do so (Di Simplicio, et al., 2009). However, 
participants of this study completed several social cognition tasks before performing the social memory task (Di 
Simplicio, et al., 2009), which may have affected their memory performance. For this reason, the findings 
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address this issue, Savaskan and colleagues (Savaskan, et al., 2008) investigated whether 
OXT also improves social memory when given during the consolidation rather than encoding 
of facial expressions. In a single-blind, placebo-controlled between-subjects design, 18 males 
and 18 females received 20 IU of OXT or PLC after viewing 60 faces (60 males; 10 s) with 
various emotional expressions (20 neutral, 20 happy, 20 angry). Thirty min and 24 hr later, 
participants completed a memory test, which required them to distinguish between 30 faces 
(self-paced) they had seen previously (10 neutral, 10 happy, 10 angry) and 20 faces (self-
paced) they had not seen previously. Notably, all faces were shown with neutral expressions 
during the memory test. Participants were asked to provide “old” and “new” ratings for each 
face and to indicate whether the face had formerly been presented with a happy or angry 
expression. OXT improved participants’ memory for all emotional expressions, after 30 min 
as well as after 24 hr. There was some, but not convincing, evidence that this effect may have 
been more pronounced for angry than happy expressions (Guastella & MacLeod, 2012), 
leaving open whether OXT affects face memory in an expression-specific way as suggested 
by Guastella and colleagues (Guastella, Mitchell, & Mathews, 2008). 
1.1.3. Summary 
Studies investigating OXT effects on social cognition via face processing tasks 
revealed impressive effects of OXT on social recognition and social memory (Bartz, et al., 
2011; Guastella & MacLeod, 2012). According to these studies, OXT improves the 
recognition (Di Simplicio, et al., 2009; Fischer-Shofty, et al., 2010; Marsh, et al., 2010) as 
well as the encoding (Guastella, Mitchell, & Mathews, 2008; Rimmele, et al., 2009) and 
consolidation (Savaskan, et al., 2008) of emotional expressions under various conditions. 
Although not entirely conclusive (Guastella & MacLeod, 2012), these effects appear to be 
                                            
regarding participants’ memory performance will not be considered in this review, following the suggestions of 
previous reviews dealing with OXT effects on social cognition (Guastella & MacLeod, 2012). 
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more pronounced during the processing of positive (Di Simplicio, et al., 2009; Guastella, 
Mitchell, & Mathews, 2008; Marsh, et al., 2010) than negative (Fischer-Shofty, et al., 2010) 
expressions. Notwithstanding these inconsistencies, the aforementioned studies consistently 
demonstrated beneficial effects of OXT on social cognition (see Table 1 and Table 2 for an 
overview of the respective studies). 
1.2. Mechanisms underlying the effects of oxytocin on social cognition 
Animal studies revealed that OXT effects on social cognition crucially depend on the 
amygdala (Choleris, Clipperton-Allen, Phan, & Kavaliers, 2009; Ferguson, Young, & Insel, 
2002). For instance, administration of OXT to the amygdala restores social memory in OXT-
R knockout mice (Ferguson et al., 2000) and administration of OXT antagonists or OXT-R 
antisense DNA to the amygdala impairs social recognition in wild type mice (Choleris et al., 
2007; Ferguson, Aldag, Insel, & Young, 2001). Motivated by these findings, Kirsch and 
colleagues (Kirsch et al., 2005) investigated for the first time whether the amygdala similarly 
mediates OXT effects on social cognition in humans (see Table 3 for an overview of similar 
studies). Using a double-blind, placebo-controlled within-subjects, they administered 27 IU of 
OXT or PLC to 15 males who had to perform a face matching task on 12 faces (5 s) showing 
angry (3 male, 3 female) or fearful (3 male, 3 female) expressions. OXT attenuated left 
amygdala activity as well as coupling of the amygdala with the brainstem, a connection 
essential for physiological reactions to emotional expressions (Adolphs, 2002). Since Kirsch 
and colleagues (Kirsch, et al., 2005) only showed that OXT attenuated amygdala reactivity to 
angry and fearful expressions, Domes and colleagues (Domes et al., 2007) investigated 
whether amygdala reactivity to happy expressions would be similarly affected by OXT. In a 
double-blind, placebo-controlled within-subjects design, 13 males received 24 IU of OXT or 
PL before they had to perform a gender discrimination task on 130 (65 male, 65 female) faces 
(2 s) depicting various expressions (10 neutral, 40 happy, 40 angry, 40 fearful) at different 
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1. Introduction   12 
intensity levels (0%, 25%, 75% and 100% of emotional intensity). OXT attenuated right 
amygdala reactivity to all emotional expressions, irrespective of the expressions’ emotional 
valence (positive, negative). Moreover, OXT also attenuated activity in the left and right 
temporal pole and left temporoparietal junction in response to happy and fearful expressions, 
suggesting that OXT modulates neural activity in various brain regions associated with face 
processing (Adolphs, 2002). Although these studies revealed that the amygdala also mediates 
OXT effects on social cognition in humans (Domes, Heinrichs, Glascher, et al., 2007; Kirsch, 
et al., 2005), they only provided limited insights into the underlying mechanisms of these 
effects. In consideration of this, Gamer and colleagues (Gamer, Zurowski, & Buchel, 2010) 
investigated how different subregions of the amygdala contribute to OXT effects on social 
cognition. In a double-blind, placebo-controlled between-subjects design, 46 males received 
24 IU of OXT or PLC before they had to perform an emotion classification task on 72 faces 
(150 ms) displaying neutral (12 male, 12 female), happy (12 male, 12 female) or fearful (12 
male, 12 female) expressions. Importantly, the faces were presented in a way that 
participants’ attention was either directed to the mouth or to the eye region of the expressions. 
OXT directed participants’ attention to the eye region of all expressions as indicated by 
corresponding changes in gaze behavior. Interestingly, these gaze changes were accompanied 
by an augmented activation of a right posterior amygdala subregion as well as by an 
augmented coupling of this amygdala subregion with the superior colliculi, a crucial 
connection for gaze changes and attention shifts (e.g., Akiyama et al., 2007; Sereno, Briand, 
Amador, & Szapiel, 2006). In addition, OXT attenuated activity for fearful expressions and 
augmented activity for happy expressions in a left anterior amygdala subregion. These 
findings clearly indicate the amygdala as the major site for OXT effects on social cognition 
(Domes, Heinrichs, Glascher, et al., 2007; Gamer, et al., 2010; Kirsch, et al., 2005)5, but also 
                                            
5 Studies investigating OXT effects on social cognition in other contexts than social recognition or social 
1. Introduction   13 
reveal that these effects are mediated by local rather than global activity changes within the 
amygdala (Gamer, et al., 2010): OXT modulated activity in subregions of the amygdala that 
were differentially engaged during attentional orienting (right posterior amygdala subregion 
in conjunction with the superior colliculi) and emotion classification (left anterior amygdala 
subregion). 
Taken together, these studies suggest that OXT effects on social cognition involve 
various mechanisms, including mechanisms related to attention allocation and mechanisms 
related to emotion recognition (Guastella & MacLeod, 2012). First of all, OXT may generally 
improve the recognition of and memory for facial expressions by enhancing attention for 
distinct facial features. Accordingly, OXT directs gaze to the eye region of a face (Gamer, et 
al., 2010; Guastella, Mitchell, & Dadds, 2008), which conveys the most informative features 
of an expression (Schyns, Bonnar, & Gosselin, 2002; Schyns, Petro, & Smith, 2007, 2009; 
Smith, Cottrell, Gosselin, & Schyns, 2005). In this regard, it is not surprising that OXT 
improves social cognition on tasks that rely on a thorough exploration of the eye region 
(Domes, Heinrichs, Michel, et al., 2007; Fischer-Shofty, et al., 2010). These gaze-related 
effects are most likely mediated by activity changes in the amygdala and superior colliculi 
(Gamer, et al., 2010). However, activity changes in the amygdala and superior colliculi may 
also account for other attention-related processes than those involving gaze changes. Changes 
in pupil size, for instance, are also mediated by activity changes in the amygdala and superior 
colliculi, presumably via projections to the locus coeruleus (e.g., Bouret, Duvel, Onat, & Sara, 
2003; Gilzenrat, Nieuwenhuis, Jepma, & Cohen, 2010; Wang, Boehnke, White, & Munoz, 
2012)6. OXT, indeed, does not only change gaze behavior (Gamer, et al., 2010; Guastella, 
                                            
memory have also shown that these effects are amygdala dependent (Baumgartner, Heinrichs, Vonlanthen, 
Fischbacher, & Fehr, 2008; Petrovic, Kalisch, Singer, & Dolan, 2008; Rilling et al., 2012). 
6 It should be noted that the exact mechanisms underlying changes in pupil size are not completely understood 
yet (Laeng, Sirois, & Gredeback, 2012). Although it has been shown that activity changes in the locus coeruleus, 
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Mitchell, & Dadds, 2008) but also pupil size (Leknes et al., 2012) during face processing, 
indicating that OXT effects on social cognition involve shifts in overt (changes in gaze 
behavior) as well as covert (changes in pupil size) attention. Second, OXT may specifically 
improve the recognition of and memory for positive as compared to negative expressions by 
decreasing the aversive value of negative expressions and increasing the appetitive value of 
positive expressions. Accordingly, OXT enhances the processing of positive rather than 
negative expressions on various social cognition tasks (Guastella & MacLeod, 2012). For 
instance, OXT attenuates the misclassification of positive expressions as negative ones (Di 
Simplicio, et al., 2009) and facilitates the recognition and encoding of positive relative to 
negative expressions (Guastella, Mitchell, & Mathews, 2008; Marsh, et al., 2010). These 
emotion-related effects are most likely mediated by differential activity changes in the 
amygdala (Gamer, et al., 2010), presumably by increased amygdala reactivity to positive 
expressions and decreased amygdala reactivity to negative expressions. However, whether 
OXT in fact improves social recognition and social memory by enhancing attention for 
distinct facial features and by changing the affective value of positive and negative 
expressions has not been studied yet. 
                                            
amygdala and superior colliculi are related to changes in pupil size (e.g., Bouret, et al., 2003; Gilzenrat, et al., 
2010; Wang, et al., 2012), it remains to be determined how these activity changes lead to pupil constriction, via 
the sphincter muscle, or pupil dilation, via the dilator muscle. 
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2. Aim 
Studies investigating the effects of OXT on social cognition revealed that OXT 
improves the recognition of and memory for facial expressions under various conditions 
(Bartz, et al., 2011; Guastella & MacLeod, 2012). On basis of these studies, it may be 
assumed that these effects are mediated by attention- and emotion-related activity changes in 
the amygdala and superior colliculi (Zink & Meyer-Lindenberg, 2012). OXT may generally 
facilitate face processing by enhancing attention for distinct facial features, probably by 
initiating shifts in overt (Gamer, et al., 2010; Guastella, Mitchell, & Dadds, 2008) and/or 
covert (Leknes, et al., 2012) attention. Additionally, OXT may specifically improve the 
recognition of and memory for positive expressions by enhancing the saliency of positive 
rather than negative expressions (Di Simplicio, et al., 2009; Gamer, et al., 2010; Guastella, 
Mitchell, & Mathews, 2008; Marsh, et al., 2010). Although previous findings are broadly 
consistent with these predictions, they have not explicitly been tested yet. In consideration of 
this, the present thesis investigated, for the first time, whether OXT indeed improves social 
cognition via the proposed mechanisms. 
Three studies were performed to investigate the effects of OXT on facial emotion 
recognition under conditions of unlimited (Study I, Study II) and limited awareness (Study 
III). In Study I and Study II, participants’ gaze behavior was recorded while they performed 
an emotion recognition task that involved the presentation of gradually changing expressions. 
These studies tested whether OXT differentially affected the recognition of positive and 
negative expressions and whether these effects were related to shifts in overt and/or covert 
attention. More precisely, Study I tested whether changes in gaze behavior and Study II tested 
whether changes in pupil size accounted for OXT effects on emotion recognition. In Study III, 
participants performed an emotion recognition task that involved the masked presentation of 
static expressions. The expressions were presented very briefly, ruling out that gaze changes 
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may have occurred during face processing. This study tested whether OXT differentially 
affected the recognition of positive and negative expressions under conditions that precluded 
shifts in overt attention. Across all three studies, it was expected that OXT would specifically 
improve the recognition of positive expressions by initiating shifts in overt and/or covert 
attention during face processing. 
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3. Materials and Methods 
3.1. Participants 
All studies were performed at the Department for Psychiatry and Psychotherapy of the 
University of Rostock. Each study was carried out in accordance with the Declaration of 
Helsinki and was approved by the local ethics committee. Forty-seven healthy males 
participated in the first two studies (Study I, Study II) and 56 healthy males participated in the 
last study (Study III)7. It should be noted, however, that the same participants were included 
in Study I and Study II, whereas different participants were included in Study III. Exclusion 
criteria for participation were medical or mental illness, use of medication, substance abuse 
and smoking. A brief interview and several self-report questionnaires were administered to 
determine exclusion of participants8. The brief interview was used to screen for medical and 
mental illness, whereas the self-report questionnaires assessed general intelligence 
(Wortschatztest, WST; Schmidt & Metzler, 1992), general psychopathology (Symptom 
Checklist-90-Revised, SCL-90-R; Franke, 1995), anxiety (State Trait Anxiety Inventory, 
STAI; Laux, Glanzmann, Schaffner, & Spielberger, 1981), anger (State Trait Anger 
Expression Inventory, STAXI; Spielberger, 1991), positive and negative affect (Positive and 
Negative Affect Scales, PANAS; Watson, Clark, & Tellegen, 1988), alexithymia (Twenty-
item Toronto Alexithymia Scale, TAS-20; Bagby, Parker, & Taylor, 1994; Bagby, Taylor, & 
Parker, 1994) and empathy (Interpersonal Reactivity Index, IRI; Davis, 1983). As none of the 
                                            
7 It is important to note that only males were included in the studies because it has recently been suggested that 
OXT effects on social cognition are sexually dimorphic (Domes, et al., 2010; Lischke, Gamer, et al., 2012a, 
2012b). However, for the ease of readability, this is not explicitly stated throughout this work when referring to 
the studies’ participants. Consequently, the term “participant” rather than “male participant” is used. 
Nonetheless, caution is warranted when generalizing the studies’ findings to female as compared to male 
populations. 
8 The interview was administered in all studies, whereas the studies differed with regard to the administered self-
report questionnaires (see Appendix). 
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participants reported a significant illness in the interview or scored in the clinical range of the 
self-report questionnaires, they were all included in the respective studies. All participants 
provided written performed consent prior to participation and were reimbursed for their time. 
3.2. Experimental procedure 
3.2.1. Substance application 
Participants were instructed to abstain from alcohol, drugs, nicotine and caffeine on 
the testing day. After arrival at the laboratory, they were randomly assigned to the OXT or 
PLC group using a double-blind, placebo-controlled between-subjects design. Following a 
standardized protocol (Domes, et al., 2010; Lischke, Gamer, et al., 2012a, 2012b), they self-
administered 24 IU of OXT (Syntocinon, Novartis, Basel, Switzerland) or PLC (containing all 
ingredients except for the neuropeptide) 45 min before the start of the experimental session. 
Substance induced changes in participants’ mental state, in terms of wakefulness, calmness 
and mood, were tracked by repeatedly administering a multidimensional mood questionnaire 
(Multidimensionaler Befindlichkeitsbogen, MDBF; Steyer, Schwenkmezger, Notz, & Eid, 
1997) throughout substance application. In addition, participants were told to report any side-
effects they may have experienced following substance application. 
3.2.2. Hormone assessment 
Blood samples were collected to control for differences in participants’ peripheral 
OXT levels before and after substance application9. The samples were drawn into 5 ml EDTA 
vacutainer tubes, immediately cooled in ice-chilled water at 4° C and later centrifuged at 4000 
rpm (for 5 min at 4° C) before they were stored in a freezer at -20° C. After completion of the 
studies, the samples were shipped on dry ice at -20° C to an external laboratory (Department 
of Behavioral and Molecular Neuroendocrinology, University of Regensburg, Germany), 
                                            
9 Although blood samples were assessed in all studies, they were not analyzed in Study III because of equipment 
malfunction. 
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where they were extracted and analyzed using a radioimmunoassay (Landgraf, 1981). The 
assay detection limit was 0.1 pg/sample, cross-reactivity with other related neuropeptides was 
< 0.7%, intra-assay precision was 7-10% and inter-assay precision was eliminated by 
measuring all samples within the same assay. 
3.3. Experimental tasks 
3.3.1. Dynamic emotion recognition task 
The emotion recognition task used in Study I and Study II involved the presentation of 
computer-manipulated faces, whose expression was gradually changing from a neutral to an 
emotional one. The faces were selected on basis of a validation study from the FACES 
database (Ebner, Riediger, & Lindenberger, 2010) and consisted of six male and six female 
faces showing a neutral, happy, angry, fearful and sad expression. Adobe Photoshop CS4 
(Adobe Systems Inc., San Jose, CA, USA) and Matlab 7.7 (MathWorks Inc., Natick, MA, 
USA) were used to prepare the faces for the emotion recognition task. At first, the faces were 
converted into grayscales and equalized in size and cumulative brightness. Thereafter, each 
face was enclosed within an elliptic mask (411 x 570 pixels) that only revealed the face itself 
while hiding hair and ears. Finally, Winmorph 3.01 (http://www.debugmode.com/winmorph/) 
was used to gradually transform each neutral expression into an emotional expression of the 
same individual face, resulting in expressions whose emotional intensity ranged from 0% 
(100% neutral) to 100% (0% neutral). During the emotion recognition task, the faces were 
presented on a 20” computer screen (resolution: 1024 x 768 pixels) against a gray 
background. The viewing distance was held constant at 55 cm by fixating participants’ head 
on a chin rest. Each trial started with a fixation cross (1 s), followed by a face with a gradually 
changing expression (800 ms per 5% increase in emotional intensity). Participants were 
instructed to watch the face and to press a stop button as soon as they detected the onset of an 
emotional expression. After stopping the presentation, they had to identify the particular 
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expression (self-paced) by making a forced-choice between four possible emotion labels 
(happy, angry, fearful, sad). For statistical purposes, the proportion of correctly recognized 
expressions (recognition accuracy) and the corresponding intensity levels of the expressions 
(recognition sensitivity or recognition threshold) were determined. The experiment was run 
on a Microsoft Windows XP operating system using Presentation 12.1 (Neurobiobehavioral 
Systems Inc., Albany, CA, USA). 
3.3.2. Static emotion recognition task 
The emotion recognition task used in Study III involved the masked presentation of 
faces with static expressions. The faces were selected on basis of a validation study from the 
KDEF database (Goeleven, De Raedt, Leyman, & Verschuere, 2008) and consisted of eight 
male and eight female faces showing a neutral, happy or angry expression. One male and one 
female face with a neutral expression were also added to the faces set. The faces were 
prepared for the emotion recognition task using Adobe Photoshop CS4 (Adobe Systems Inc., 
San Jose, CA, USA) and Matlab 7.7 (MathWorks Inc., Natick, MA, USA). After converting 
the faces into grayscales, they were equalized in size and cumulative brightness. Finally, they 
were enclosed in a rectangular mask (286 x 269 pixels) that only revealed the face itself while 
hiding the hair and ears. During the emotion recognition task, the faces were presented on a 
17” computer screen (resolution: 800 x 600 pixels) against a gray background. Each trial 
started with a fixation cross (1 s) and a blank screen (100 ms). Then a face with a neutral, 
happy or angry expression was presented for 18, 35 or 53 ms, immediately followed by a face 
with a neutral expression which served as a “mask” (165 ms). The faces were randomly 
presented in a block-wise fashion, with 12 neutral, happy and angry expressions per block. 
Prior to each block, participants were informed whether the target expression was a happy or 
an angry one (4 happy blocks, 4 angry blocks). The neutral expression always served as a 
distractor. After the presentation of each expression, they had to indicate whether the target 
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expression had been shown or not (3 s). For statistical purposes, the proportion of correctly 
recognized expressions in terms of hits and false alarms was determined. On basis of these hit 
and false alarm rates, indices for recognition accuracy (d’) and response bias (c) were 
calculated (Snodgrass & Corwin, 1988). The experiment was run on a Microsoft Windows 
XP operating system using Matlab 7.7 (MathWorks Inc., Natick, MA, USA). 
3.4. Eye-tracking 
3.4.1. Data acquisition 
In Study I and Study II a remote eye-tracker (ViewPoint PC-60 Head-Fixed; Arrington 
Research Inc., Scottsdale, AZ, USA) was used to record participants’ gaze behavior during 
face processing. Gaze position was sampled at a rate of 60 Hz with a spatial resolution of 
0.15° for tracking resolution and 0.25°-1.0° for gaze position accuracy. Pupil size was also 
sampled at a rate of 60 Hz with an overall accuracy of 0.03 mm. The recorded data was then 
analyzed with in-house software written in Matlab 7.13 (MathWorks Inc., Natick, MA, USA). 
3.4.2. Data analysis with respect to fixation patterns 
In Study I gaze changes were analyzed using GazeAlyze (Berger, Winkels, Lischke, & 
Hoppner, 2012), a software package written in Matlab 7.13 (MathWorks Inc., Natick, MA, 
USA)10. After smoothing of the data, blinks were interpolated as longs as the blink period did 
not exceed more than 20% of a trial with correctly recognized expressions. Otherwise, data 
for this trial was excluded from the analysis. Fixations were coded when gaze remained for at 
least 100 ms within an area with a size of 1°. Using these criteria, the number and duration of 
fixations was determined for distinct facial regions, including the face itself (elliptic mask: 
411 x 750 pixels), the mouth (rectangular mask: 223 x 87 pixels) and the eyes (rectangular 
                                            
10 Initially, the eye-tracking data was analyzed with in-house software written in Matlab 7.7 (MathWorks Inc., 
Natick MA, USA). The software used algorithms implemented in ILAB (Gitelman, 2002), which were later 
incorporated into the software package GazeAlyze (Berger, et al., 2012). 
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mask: 354 x 123 pixels). For statistical purposes, the duration and number of fixations to the 
face relative to the background, to the eyes relative to the face and to the mouth relative to the 
face were calculated. In order to investigate OXT effects on gaze behavior over the time 
course of expression formation, these ratios were determined for fixations occurring during 
the first 1.6 s of a trial (initial fixation changes) as well as for fixations occurring throughout 
the whole trial (overall fixation changes). 
3.4.3. Data analysis with respect to pupillary responses 
In Study II pupillary responses were analyzed using an unpublished software package 
written in Matlab 7.13 (MathWorks Inc., Natick, MA, USA). After smoothing of the data and 
blink interpolation, pupil dilation difference scores (baseline correction) were determined for 
trials with correctly recognized expressions. For each trial, the pupil diameter of the 200 ms 
preceding the onset of an emotional expression was subtracted from the pupil diameter 
following the onset of an emotional expression (interval of interest ranging from 800 ms to 
3200 ms after expression onset). The difference in pupil diameter was used for statistical 
purposes. 
3.5. Statistical analyses 
All statistical analyses were performed using SPSS 20 (IBM SPSS Inc., Chicago, IL, 
USA)11. Most analyses relied on (mixed-design) analyses of variance (ANOVAs), whose 
significant main and interaction effects were further specified by sub-ANOVAs and t tests for 
dependent and independent samples. Additional analyses, in particular exploratory ones, 
involved t tests for dependent and independent samples, zero-order correlations and multiple 
                                            
11 Although different versions of SPSS (IBM SPSS Inc., Chicago, IL, USA) were used for the statistical analyses 
in the three studies, a re-analysis of the respective data with the latest SPSS version, that is SPSS 20 (IBM SPSS 
Inc., Chicago, IL, USA), revealed similar results. However, this thesis only provides a summary of the most 
important results. A detailed description of all results is given in the respective passages of the corresponding 
publications (see Appendix). 
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regressions. Whenever appropriate, the degrees of freedom were adjusted to control for 
violations of the homoscedasticity and sphericity assumption. The significance level for all 
analyses was set at p < .05 (two-sided). In case of (marginally) significant results, Cohen’s f 
or Cohen’s d are reported as effect size estimates (Cohen, 1988). 
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4. Results 
4.1. Participant characteristics 
None of the participants reported a significant illness in the interview or scored in the 
clinical range of the self-report questionnaires. Consequently, there were no differences 
between participants of the OXT and PLC group in terms of age, general intelligence or 
psychopathology [Study I and Study II: F < 2.72, p > .05 for all effects; Study III: F < 0.09, p 
> .05 for all effects]. 
4.2. Substance application 
There were some changes in participants’ wakefulness [Study I and Study II: F < 1.55, 
p > .05 for all main effects of group and group by time interactions, F(1,45) = 38.94, p < .05, f 
= 0.92 for main effect of time; Study III: F < 0.54, p > .05 for all group- and time-related 
main effects and interactions] but not mood [Study I, Study II and Study III: F < 3.02, p > .05 
for all group- and time-related main effects and interactions] or calmness [Study I, Study II 
and Study III: F < 1.43, p > .05 for all group- and time-related main effects and interactions] 
ratings over the time course of substance application. However, these ratings did not differ 
between participants of the OXT and PLC group, indicating that the observed changes were 
time- rather than substance-dependent. Accordingly, participants reported, if at all, only subtle 
side effects (e.g., tiredness, weariness) following substance application.  
As expected, there were substantial changes in participants’ peripheral OXT levels 
throughout substance application12: While OXT levels were comparable between participants 
of the OXT and PLC group before substance application, they differed between participants 
after substance application, with participants of the OXT group displaying higher OXT levels 
                                            
12 Although changes in peripheral OXT levels could only be investigated in Study I and Study II, it may be 
assumed that similar changes occurred in Study III because all studies used the same substance application 
protocol. 
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than participants of the PLC group [Study I and Study II: F < 3.79, p > .05 for all time- and 
group-related main effects; F(1,45) = 26.94, p < .001, f = 0.76 for group by time interaction].  
4.3. Emotion recognition under conditions of unlimited awareness 
4.3.1. Emotion recognition 
Participants of the OXT group recognized all emotional expressions at lower intensity 
levels than participants of the PLC group, indicating that OXT generally rather than 
specifically enhanced participants’ recognition sensitivity [Study I and Study II: F > 4.86, p < 
.05 for all main effects of group; F < 1.32, p > .05 for all group by emotion interactions]. 
There was, however, some evidence suggesting that these effects were more pronounced for 
fearful [Study I: t(45) = 2.67, p < .05, d = 0.59 for both, male and female faces; Study II: t(45) 
= 1.97, p < .06, d = 0.57 and t(45) = 1.83, p < .07, d = 0.54 for male and female faces, 
respectively] and angry [Study I: t(45) = 2.01, p < .05, d = 0.78 for both, male and female 
faces; Study II: t(45) = 2.17, p < .05, d = 0.64 and t(45) = 2.73, p < .001, d = 0.80 for male 
and female faces, respectively] expressions than for all other expressions [Study I and Study 
II: t < 1.73, p > .05 for all faces with happy and sad expressions]. Besides this, participants’ 
recognition thresholds were generally low for happy expressions, moderate for angry and 
fearful expressions and high for sad expressions [Study I and Study II: F > 75.04, p < .001, f > 
1.29 for all main effects of emotion]. Of note, these effects were essentially the same for male 
and female faces, indicating that the sex of the faces had no substantial effect on participants’ 
recognition sensitivity [Study II: F < 1.80, p > .05 for all sex-related main effects and 
interactions]. 
Participants of the OXT and PLC group did not differ from one another with regard to 
the number of correctly recognized expressions, indicating that OXT had no general effect on 
participants’ recognition accuracy [Study I and Study II: F < 1.54, p > .05 for all main effects 
of group and group by emotion interactions]. However, there was some evidence suggesting 
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that OXT specifically enhanced participants’ recognition accuracy for fearful [Study I: t(45) = 
2.36, p < .05; d = 0.69 for both, male and female faces; Study II: t(45) = 1.83, p < .08, d = 
0.54 and t(37.87) = 2.14, p < .05, d = 0.64 for male and female faces, respectively] and sad 
[Study II: t(45) = 1.83, p < .10, d = 0.49 and t(45) = 1.95, p < .06, d = 0.57 for male and 
female faces, respectively] expressions as compared to all other expressions [Study I: t < 0.13, 
p > .05 for all faces with happy, angry or sad expressions; Study II: t < 1.58, p > .05 for all 
faces with happy or angry expressions]. Apart from that, participants’ recognition accuracy 
was generally high for happy expressions, moderate for angry and fearful expressions and low 
for sad expressions [Study I and Study II: F > 34.42, p < .001, f > 0.87 for all main effects of 
emotion]. Interestingly, these effects differed for male and female faces, indicating that the 
sex of the faces had an effect on participants’ recognition accuracy [Study II: F > 4.41, p < 
.001, f > 0.31 for main effect of sex and emotion by sex interaction; F(1,45) = 0.63, p > .05 
for group by sex interaction]. Participants were generally more accurate in recognizing happy 
expressions in male as compared to female faces and more accurate in recognizing angry, 
fearful and sad expressions in female as compared to male faces. Moreover, OXT even 
appeared to differentially affect participants’ recognition accuracy for distinct expressions in 
male and female faces [Study II: F(2.25,101.25) = 6.93, p < .001, f = 0.39 for group by 
emotion by sex interaction]: There was some, albeit not substantial, evidence suggesting that 
the aforementioned effects of OXT on participants’ recognition accuracy for fearful and sad 
expressions were more pronounced during the processing of female than male faces [Study II: 
t(45) = 1.83, p < .08, d = 0.54 and t(37.87) = 2.14, p < .05, d = 0.64 for male and female faces 
with fearful expressions, t(45) = 1.83, p < .10, d = 0.49 and t(45) = 1.95, p < .06, d = 0.57 for 
male and female faces with sad expressions, respectively]. 
4.3.2. Fixation patterns 
The duration of fixations that were initially or subsequently directed to a face did not 
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differ between participants of the OXT and PLC group, neither when considering fixations in 
general nor when considering expression-specific fixations [Study I: F < 1.27, p > .05 for all 
emotion- and group-related main effects and interactions]. Similarly, there were no 
differences between participants of the OXT and PLC group regarding the duration of 
fixations that were initially or subsequently directed to distinct facial regions [Study I: F < 
0.84, p > .05 for all group-related main effects and interactions]. However, participants’ 
fixation duration was generally longer for the eye than for the mouth region of a face [Study I: 
F > 200.98, p < .001, f > 2.22 for all main effects of region], especially during the processing 
of angry, fearful and sad as compared to happy expressions [Study I: F > 13.18, p < .001, f > 
0.57 for all region by emotion interactions and F < 1.018, p > .05 for all main effects of 
emotion]. 
Although OXT had no substantial effect on participants’ fixation patterns, there was 
some, albeit limited, evidence suggesting that OXT mediated the association between 
participants’ fixation patterns and emotion recognition performance. Accordingly, OXT may 
have specifically enhanced participants’ recognition sensitivity for sad expressions by 
increasing the duration of fixations that were directed to the eye region of these expressions 
[Study I: t(144) = 2.14, p < .05; r(20) = -.52, p < .05 for OXT-mediated association between 
overall fixation duration and recognition sensitivity for sad expressions; t(144) < 1.52, p > .05 
for all other OXT-mediated associations between fixation duration and recognition sensitivity 
or recognition accuracy].  
4.3.3. Pupillary responses 
Participants of the OXT group showed greater pupil dilation during emotion 
recognition than participants of the PLC group [Study II: F(1,45) = 4.06, p = .05, f = 0.29 for 
main effect of group], in particular during the processing of male as compared to female faces 
[Study II: F > 5.36, p < .05, f > 0.35 for main effect of sex and group by sex interaction]. 
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These effects were essentially the same for happy, angry, fearful and sad expressions, 
indicating that the emotional valence of a particular expression had no substantial effect on 
participants’ pupillary responses [Study II: F < 1.29, p > .05 for all emotion-related effects 
and interactions]. Importantly, baseline differences in participants’ pupil size did not account 
for the observed changes in pupil size [Study II: F < 1.60, p > .05 for all group-, sex- and 
emotion-related main effects and interactions]. 
4.4. Emotion cognition under conditions of limited awareness 
Participants of the OXT group recognized more expressions, especially positive ones, 
than participants of the PLC group, indicating that OXT specifically enhanced participants’ 
recognition accuracy for happy expressions [Study III: F > 4.55, p < .05, f > .29 for main 
effect of group and group by emotion interaction; F < 2.97, p < .05 for group by time 
interaction and group by time by emotion interaction]. However, happy expressions were 
generally better recognized than angry expressions, in particular with increasing presentation 
times [Study III: F > 3.75, p < .05, f > .26 for main effect of emotion, main effect of time and 
time by emotion interaction]. Differences in task difficulty may, thus, have mediated the 
observed effects of OXT on participants’ recognition accuracy. 
Besides this, participants’ recognition accuracy was biased in a conservative rather 
than liberal direction, particularly during the processing of happy expressions that were 
presented at longer presentation times [Study III: F > 8.25, p < .05, f > 0.39 for main effect of 
emotion, main effect of time and time by emotion interaction]. This bias was more 
pronounced for participants of the OXT than PLC group, albeit equally strong for angry and 
happy expressions [Study III: F(2,108) = 5.01, p < .05, f > 0.39 for group by time interaction; 
F < 2.82, p > .05 for main effect of group, group by emotion interaction and group by time by 
emotion interaction]. 
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5. Discussion 
Previous studies investigating the effects of OXT on social cognition revealed that 
OXT improves the recognition of and memory for facial expressions under various conditions 
(Bartz, et al., 2011; Guastella & MacLeod, 2012), probably due to attention- and emotion-
related activity changes in the amygdala and superior colliculi (Zink & Meyer-Lindenberg, 
2012). The respective findings suggest that various mechanisms, either in concert or alone, 
contribute to OXT effects on social cognition: OXT may generally facilitate face processing 
by overtly and/or covertly directing attention to distinct facial features (Gamer, et al., 2010; 
Guastella, Mitchell, & Dadds, 2008; Leknes, et al., 2012) and OXT may specifically facilitate 
the processing of positive as compared to negative expressions by changing the affective 
value of these expressions (Di Simplicio, et al., 2009; Gamer, et al., 2010; Guastella, Mitchell, 
& Mathews, 2008; Marsh, et al., 2010). The aim of the present thesis was to investigate 
whether OXT in fact improves face processing via the proposed mechanisms. To this end, 
three studies were performed to examine how OXT affects the recognition of positive and 
negative expressions under conditions of unlimited (Study I, Study II) and limited (Study III) 
awareness. 
5.1. Emotion recognition under conditions of unlimited awareness 
In Study I and Study II, participants’ gaze behavior was recorded while they 
performed an emotion recognition task that involved the presentation of dynamically 
changing expressions. The studies investigated whether OXT differentially affected 
participants’ recognition sensitivity and recognition accuracy for positive and negative 
expressions and whether these effects were accompanied by shifts in overt (changes in gaze 
behavior in terms of fixation patterns) and/or covert (changes in pupil size in terms of 
pupillary responses) attention  
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5.1.1. Emotion recognition 
In Study I and Study II, OXT enhanced participants’ recognition sensitivity for all 
expressions, irrespective of the expressions’ emotional valence, but had no effect at all on 
participants’ recognition accuracy. Importantly, there was no evidence indicating that OXT 
specifically improved the recognition of positive as compared to negative expressions. On the 
contrary, there was even some evidence suggesting that OXT improved the recognition of 
negative rather than positive expressions: OXT effects on emotion recognition were more 
pronounced during the processing of angry and fearful than happy expressions. However, due 
to the exploratory nature of the respective analyses, these findings should be regarded as 
preliminary unless replicated in future studies. Consequently, there was more evidence 
indicating that OXT generally rather than specifically affected participants’ recognition 
accuracy. 
Previous studies, in contrast, reported specific and not general effects of OXT on face 
processing (Di Simplicio, et al., 2009; Fischer-Shofty, et al., 2010; Guastella, Mitchell, & 
Mathews, 2008; Marsh, et al., 2010). Moreover, most of these studies found that OXT 
specifically affected the processing of happy instead of angry or fearful expressions (Di 
Simplicio, et al., 2009; Guastella, Mitchell, & Mathews, 2008; Marsh, et al., 2010). However, 
these studies used static expressions for the emotion recognition task, whereas dynamic 
expressions were used in the present studies. Dynamically changing expressions convey more 
emotion-specific information than static ones (Ambadar, Schooler, & Cohn, 2005), which 
may explain why participants’ recognition accuracy was quite high in these studies. This was 
most evident during the processing of happy expressions, which were already perfectly 
recognized at low intensity levels (ceiling effects). OXT may, thus, have had no chance to 
further improve participants’ recognition accuracy for these expressions in the present studies. 
Although the majority of previous studies demonstrated that OXT specifically improved the 
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recognition of happy expressions (Di Simplicio, et al., 2009; Marsh, et al., 2010), one study 
found OXT that specifically improved the recognition of fearful expressions (Fischer-Shofty, 
et al., 2010), albeit in terms of recognition accuracy and not recognition sensitivity. 
Interestingly, this was the only study that also used dynamic expressions for the emotion 
recognition task. However, this study used partial displays of faces that only revealed the eye 
region during expression formation, whereas full displays of faces were shown in the present 
studies. The use of partial face displays may have biased emotion recognition towards 
expressions whose recognition critically depend on the eye region, such as fearful expressions 
(Adolphs, 2008). This may explain why OXT specifically enhanced participants’ recognition 
accuracy for fearful expressions in this study, while leaving their recognition accuracy for 
other expressions unaffected (Fischer-Shofty, et al., 2010). However, in the same study, OXT 
had no effect on participants’ recognition sensitivity for fearful expressions, which seems to 
be at odds with the aforementioned explanation. The absence of a change in participants’ 
recognition sensitivity was most likely due to the rapid unfolding of expressions (ceiling 
effects). In the present studies, on the contrary, the expressions were unfolding less rapidly, 
thereby leaving room for OXT to improve participants’ recognition sensitivity. Differences in 
task design may, thus, account for the divergent effects of OXT on participants’ recognition 
sensitivity. 
5.1.2. Fixation patterns 
In Study I, OXT had no effect at all on participants’ gaze changes that initially or 
subsequently occurred throughout face processing. Accordingly, gaze changes did not appear 
to account for participants’ improvements in emotion recognition following OXT 
administration. In fact, there was only some evidence suggesting that OXT enhanced 
participants’ recognition sensitivity for sad expressions by directing participants’ gaze to the 
eye region of these expressions. It remains unclear why this effect was limited to sad 
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expressions, considering that expression-specific effects of OXT on emotion recognition and 
eye gaze have so far only been reported for fearful (Fischer-Shofty, et al., 2010; Gamer, et al., 
2010) and happy (Di Simplicio, et al., 2009; Gamer, et al., 2010; Guastella, Mitchell, & 
Mathews, 2008; Marsh, et al., 2010) expressions. In this regard, it is important to note that 
this finding emerged in a series of exploratory follow-up analyses, rendering it preliminary 
unless replicated in future studies. 
Although previous studies have never explicitly tested whether OXT effects on 
emotion recognition are mediated by changes in gaze behavior, they nonetheless 
demonstrated that OXT enhanced eye gaze under various conditions (Gamer, et al., 2010; 
Guastella, Mitchell, & Dadds, 2008)13.The failure to find an effect of OXT on participants’ 
gaze behavior in the present study is, thus, in sharp contrast with previous studies. However, 
these studies used static expressions, whereas dynamically changing expressions were used in 
the present study. Besides this, the expressions were much longer presented in the present 
study than in the other studies. Of note, the distribution of emotion-specific features differs 
remarkably between static and dynamic expressions (Ambadar, et al., 2005). Normally, the 
eye region conveys the most important features for emotion recognition (Schyns, et al., 2002; 
Schyns, et al., 2007, 2009; Smith, et al., 2005). This is particular true for static expressions, 
but in dynamic expressions such features are also provided by other regions, such as the 
mouth region (Kennedy & Adolphs, 2010). OXT may, thus, direct gaze to eye region of static 
rather than dynamic expressions, especially when time is too short to gaze to other regions 
than those that provide the most relevant information for emotion recognition. This may 
explain why OXT enhanced eye gaze in previous studies (Gamer, et al., 2010; Guastella, 
Mitchell, & Dadds, 2008) but not in the present study. Accordingly, other attention-related 
                                            
13 Enhanced eye gaze following OXT application has also been reported in a study investigating OXT effects in 
ASD (Andari et al., 2010), suggesting that OXT may have similar effects on eye gaze in individuals with 
(Andari, et al., 2010) and without (Gamer, et al., 2010; Guastella, Mitchell, & Dadds, 2008) mental disorders. 
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processes than those involving gaze changes must have mediated OXT effects on emotion 
recognition in Study I. Considering that gaze changes indicate shifts in overt rather than 
covert attention, it may be possible that covert attention shifts accounted for the observed 
effects. 
5.1.3. Pupillary responses 
In Study II, OXT increased participants’ pupil diameter in response to all emotional 
expressions, in particular to those expressions that were displayed by male as compared to 
female faces. Interestingly, pupil dilation was generally greater for female than male faces, 
indicating that OXT increased pupil size during the processing of male faces rather than 
decreasing pupil size during the processing of female faces. Notably, changes in pupil size are 
indicative of shifts in covert attention, implying that OXT generally enhanced participants’ 
attention during face processing, especially for those expressions that usually attract less 
attention (e.g., happy expressions displayed by male faces). 
Similar effects of OXT on pupillary responses have recently been reported in a study 
investigating OXT effects on implicit and explicit emotion recognition (Leknes, et al., 2012). 
In this study, OXT also increased participants’ pupil size for all expressions, even for those 
expressions whose emotional valence has been rendered ‘invisible’ by manipulating the low- 
and high-frequency spectrum of the expressions. Moreover, these changes in pupil size were 
related to participants’ improvements in recognition accuracy following OXT administration. 
It may, thus, indeed be possible that shifts in covert rather than overt attention contributed to 
OXT effects on emotion recognition in Study I. 
5.2. Emotion recognition under conditions of limited awareness 
In Study III, participants performed an emotion recognition task that involved the 
presentation of expressions whose emotional valence was subsequently masked by neutral 
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expressions. The expressions were presented very briefly, ruling out that gaze changes may 
have occurred during face processing14. Like in Study I and Study II, the effects of OXT on 
participants’ recognition accuracy for positive and negative expressions were investigated. 
However, in contrast to Study I and Study II, it was possible to study these effects in the 
absence of gaze changes.  
OXT enhanced participants’ recognition accuracy for all expressions, irrespective of 
the expressions’ emotional valence or presentation time. There was some evidence suggesting 
that this effect was more evident during the processing of happy than angry expressions, but 
this was probably due to the fact that happy expressions were generally better recognized than 
angry expressions, in particular with increasing presentation times (ceiling effects). Taking 
these differences in task difficulty into account, OXT generally rather than specifically 
affected participants’ recognition accuracy, presumably in a conservative rather than liberal 
way. 
Although it remains inconclusive whether OXT specifically improved the recognition 
of positive as compared to negative expressions, the present study revealed that OXT had 
similar effects on emotion recognition as in previous studies (Di Simplicio, et al., 2009; 
Fischer-Shofty, et al., 2010; Guastella, Mitchell, & Mathews, 2008; Marsh, et al., 2010). 
Previous studies suggested that these effects were due to gaze changes during face processing 
(Gamer, et al., 2010; Guastella, Mitchell, & Dadds, 2008), but the present study showed that 
these effects were even present in the absence of gaze changes. Consequently, other attention-
related processes than those involving shifts in overt attention must have mediated OXT 
effects on emotion recognition in Study III. 
                                            
14 Fixations generally have a latency of 100-200 ms following stimulus onset and usually have to last at least 100 
ms to be further processed in brain areas involved in face processing (Noton & Stark, 1971). Since the emotional 
expressions were presented for less than 100 ms and were subsequently masked with a neutral expression, it was 
quite unlikely that fixations actually occurred during expression presentation. 
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5.3. Mechanisms underlying the effects of oxytocin on emotion recognition 
The present studies demonstrated that OXT improved emotion recognition under 
conditions of unlimited (Study I, Study II) and limited awareness (Study III), irrespective of 
the expressions’ emotional valence (Study I, Study II, Study III). Previous studies, on the 
contrary, revealed expression-specific effects of OXT on emotion recognition (Di Simplicio, 
et al., 2009; Fischer-Shofty, et al., 2010; Marsh, et al., 2010). Most of these studies found that 
OXT improved the processing of positive relative to negative expressions (Di Simplicio, et 
al., 2009; Marsh, et al., 2010), although specific effects for negative expressions have also 
been reported (Fischer-Shofty, et al., 2010). In the present studies, however, there was no 
convincing evidence indicating that OXT differentially affected the processing of positive and 
negative expressions. 
Previous studies suggested that OXT improves emotion recognition by enhancing 
overt attention for distinct facial features (Gamer, et al., 2010; Guastella, Mitchell, & Dadds, 
2008). However, these studies only showed that OXT directs gaze to the eye region, but did 
not explicitly test whether gaze changes actually lead to improvements in emotion 
recognition. Study I was explicitly designed to address this issue, but failed to provide 
substantial evidence indicating that gaze changes accounted for OXT effects on emotion 
recognition. Moreover, Study III demonstrated that OXT improved emotion recognition even 
under conditions that precluded gaze changes. Accordingly, it seems possible that OXT 
effects on emotion recognition do not necessarily have to involve shifts in overt attention. 
Shifts in covert attention, for example, may also account for OXT effects on emotion 
recognition as suggested by a recent study examining how OXT affects pupillary responses to 
emotional expressions (Leknes, et al., 2012). Study II replicated this study by showing that 
OXT-induced improvements in emotion recognition were accompanied by changes in pupil 
size. Of note, Study I and Study II were based on data obtained during the same experimental 
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session, suggesting that OXT affected emotion recognition via covert rather than overt shifts 
in attention. It may also be possible that shifts in covert attention accounted for OXT effects 
on emotion recognition in Study III, but this has to remain speculative because pupillary 
responses were not recorded in this study. Nonetheless, the present studies strongly suggest 
that OXT improves emotion recognition even in the absence of overt attention shifts, probably 
due to shifts in covert attention. 
Although these conclusions appear to be quite plausible, they should be treated with 
caution for several reasons. First of all, the sample sizes in all three studies may have been too 
small to reveal more subtle effects of OXT on emotion recognition and attentional orienting. 
OXT effects during the processing of positive and negative expressions in male and female 
faces, for instance, may have become more pronounced in larger samples. Second, the 
samples of the first two studies were overlapping, indicating that the respective findings were 
not independent from one another. However, using non-overlapping samples may have 
limited a thorough investigation of the differential effects of OXT on covert and overt 
attention shifts during the same emotion recognition task. Third, the samples in all studies 
consisted of males but not females. The present findings can, therefore, not be generalized to 
females, which may be problematic considering that OXT appears to exert sex-specific effects 
on social cognition (Domes, et al., 2010; Lischke, Gamer, et al., 2012a, 2012b). Fourth, 
changes in pupil size and gaze behavior were only recorded in the first two studies but not in 
the third study. Although the task design of the latter study may have precluded gaze changes 
during face processing, it cannot entirely be ruled out that gaze changes did not account for 
OXT effects on emotion recognition. Similarly, it can only be speculated that changes in pupil 
size contributed to improvements in emotion recognition. Fifth, the modulatory effect of OXT 
on brain activity was not assessed in any of the present studies. Consequently, it remains open 
whether OXT effects on face processing are indeed mediated by attention- and emotion-
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related activity changes in the amygdala and superior colliculi (Zink & Meyer-Lindenberg, 
2012). Sixth, genetic alterations of the OXT system were also not assessed in the present 
studies, leaving open whether genetic variants of the OXT-R or CD38 gene influenced OXT 
effects on emotion recognition and attention allocation (Ebstein, et al., 2012). Taking these 
limitations into account, it becomes obvious that future studies are needed to further 
investigate how OXT affects social cognition, preferably at both, the behavioral and neural 
level. 
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6. Conclusion 
The present studies demonstrated that OXT improves emotion recognition under 
conditions of unlimited (Study I, Study II) and unlimited (Study III) awareness, presumably 
by initiating shifts in overt (Study I) and/or covert (Study II, Study III) attention during face 
processing. Although these findings should be treated with caution unless replicated and 
extended in future studies, they may nonetheless be relevant for researchers investigating 
OXT effects on social cognition as well as for clinicians treating individuals with social 
deficits  
6.1. Research implications 
The findings of the present studies are broadly consistent with those of previous 
studies, although it remains inconclusive whether OXT effects on emotion recognition and 
attention allocation are more pronounced during the processing of positive or negative 
expressions (Di Simplicio, et al., 2009; Domes, Heinrichs, Glascher, et al., 2007; Domes, 
Heinrichs, Michel, et al., 2007; Fischer-Shofty, et al., 2010; Gamer, et al., 2010; Guastella, 
Mitchell, & Dadds, 2008; Kirsch, et al., 2005; Leknes, et al., 2012; Marsh, et al., 2010). 
Inconsistencies between the present and previous studies are most likely due to methodical 
differences in terms of sample characteristics (e.g., gender composition), substance 
application (e.g., spray dosing) or experimental task (e.g., stimulus presentation), indicating 
that OXT effects on attention and emotion recognition are highly context- and person-
dependent (see Tables 1-3 for a detailed account of the studies’ methodical differences). 
Clearly, further studies are warranted that systematically investigate how situational and 
individual factors influence attention- and emotion-related effects of OXT (Bartz, et al., 
2011). In this respect, it may be particularly interesting to compare OXT effects on attention 
and emotion recognition between males and females because sex-differences in oxytocinergic 
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functioning have recently been reported (Domes, et al., 2010; Lischke, Gamer, et al., 2012a, 
2012b). 
Notwithstanding these inconsistencies, the studies as a whole demonstrated that OXT 
facilitates emotion recognition (Di Simplicio, et al., 2009; Domes, Heinrichs, Michel, et al., 
2007; Fischer-Shofty, et al., 2010; Marsh, et al., 2010) and attention allocation (Gamer, et al., 
2010; Guastella, Mitchell, & Dadds, 2008; Leknes, et al., 2012) on various tasks, regardless 
whether these tasks require basal or complex processing of emotionally relevant information 
(Bartz, et al., 2011; Guastella & MacLeod, 2012). Accordingly, OXT affects emotion 
recognition at early perceptual (e.g., detection of emotional expressions) as well as late 
conceptual (e.g., evaluation of emotional expressions) stages of face processing, possibly 
more in the context of positive as compared to negative expressions (Guastella & MacLeod, 
2012). However, the effects of OXT over the time course of face processing are not 
completely understood yet (e.g., Guastella, Carson, Dadds, Mitchell, & Cox, 2009), indicating 
a need for further studies examining how OXT affects the recognition of positive and negative 
expressions at different processing stages. 
Although the present studies suggested that OXT improves emotion recognition by 
enhancing attention for salient facial features (Bartz, et al., 2011; Guastella & MacLeod, 
2012), the exact mechanisms underlying these effects remain to be determined. Previous 
studies indicated that these effects are mediated by attention- and emotion-related activity 
changes in the amygdala and superior colliculi (Domes, Heinrichs, Glascher, et al., 2007; 
Gamer, et al., 2010; Kirsch, et al., 2005), but it is unresolved whether these activity changes 
are due to direct or indirect actions of OXT on the corresponding receptors (Zink & Meyer-
Lindenberg, 2012). In fact, little is known about the expression and distribution of the OXT-R 
in the human brain (Meyer-Lindenberg, et al., 2011), leaving open whether OXT acts on 
specific receptors in the amygdala and superior colliculi. Moreover, even if these receptors are 
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located in the amygdala and superior colliculi, it is largely unknown how other neuropeptides 
and neurotransmitter influence OXT actions on these receptors (Meyer-Lindenberg, et al., 
2011). Consequently, future studies are needed that further investigate how OXT affects 
amygdala and superior colliculi activity during face processing. These studies should ideally 
combine imaging (e.g., OXT-R mapping via positron emission tomography), genetic (e.g., 
OXT-R genotyping via haplotype analysis) and pharmacologic (e.g. OXT-R blocking via 
antagonists) methods to fully delineate the mechanisms accounting for OXT effects on social 
cognition on the neural and behavioral level.  
6.2. Clinical implications 
The present studies suggest that OXT may generally be useful for treating individuals 
with marked deficits in social cognition, like, for example, individuals suffering from ASD, 
SAD or BPD (Meyer-Lindenberg, et al., 2011). However, OXT may be particularly relevant 
for the treatment of ASD because alterations of the OXT system have been found to be 
implicated in the disorders’ etiology and pathogenesis (Bartz & Hollander, 2008; J. J. Green 
& Hollander, 2010). For example, individuals with ASD show decreased OXT (Andari, et al., 
2010; Modahl et al., 1998) and increased OXT precursor plasma levels (L. Green et al., 
2001), indicating abnormalities in OXT synthesis. Accordingly, genetic variants of the CD38 
gene, a protein that is involved in the regulation of OXT synthesis (Jin et al., 2007), are 
related to decreased OXT plasma levels in ASD (Munesue et al., 2010). Moreover, genetic 
variants of the CD38 (Lerer et al., 2010; Munesue, et al., 2010) and the OXT-R (e.g., Jacob et 
al., 2007; Lerer et al., 2008; Wermter et al., 2010; Wu et al., 2005; Ylisaukko-oja et al., 2006; 
Yrigollen et al., 2008) gene are associated with the presence of ASD, suggesting that genetic 
alterations of OXT synthesis and OXT transmission confer risk for ASD (Ebstein, et al., 
2012). Increasing OXT availability by exogenously administering OXT may, therefore, help 
to ameliorate ASD-related deficits in social cognition, such as difficulties in emotion 
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recognition (e.g., Ashwin, Chapman, Colle, & Baron-Cohen, 2006; Baron-Cohen, et al., 2001; 
Clark, Winkielman, & McIntosh, 2008; Humphreys, Minshew, Leonard, & Behrmann, 2007) 
or abnormalities in gaze behavior (e.g., Corden, Chilvers, & Skuse, 2008; Kirchner, Hatri, 
Heekeren, & Dziobek, 2010; Kliemann, Dziobek, Hatri, Steimke, & Heekeren, 2010). 
Interestingly, these deficits are associated with structural and functional alterations of the 
amygdala and superior colliculi (e.g., Dalton et al., 2005; Dziobek, Bahnemann, Convit, & 
Heekeren, 2010; Kleinhans et al., 2011; Kliemann, Dziobek, Hatri, Baudewig, & Heekeren, 
2012; Nacewicz et al., 2006), which are crucial for OXT effects on social cognition (Meyer-
Lindenberg, et al., 2011; Zink & Meyer-Lindenberg, 2012). Administering OXT to 
individuals with ASD may possibly normalize aberrant amygdala and superior colliculi, 
thereby facilitating emotion recognition and attentional orienting as suggested by the present 
studies. Notably, it has recently been shown that OXT administration improved emotion 
detection (Guastella, et al., 2010) and attentional orienting (Andari, et al., 2010) in individuals 
with ASD, indicating that OXT may indeed be useful for treating social deficits in ASD 
(Bartz & Hollander, 2008; J. J. Green & Hollander, 2010). Moreover, these studies suggest 
that OXT may also be helpful for the treatment of other mental disorders that are marked by 
deficits in social cognition, such as SAD or BPD (Meyer-Lindenberg, et al., 2011). 
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Abstract 
Previous studies have shown that oxytocin improves the encoding and recognition of 
facial expressions, which has been proposed to be mediated by an increased exploration of the 
eye region during face processing. In the present study, we used eye-tracking to assess visual 
attention to the eye region while participants performed a dynamic facial emotion recognition 
task. In a double-blind, placebo-controlled between-subjects design, 47 participants received 
24 IU of oxytocin (n = 24) or placebo (n = 23). Although oxytocin administration had no 
effect on participants’ visual scanning of the faces, it generally enhanced recognition 
performance, as the oxytocin group recognized emotional expressions at lower intensity levels 
than the placebo group. These findings suggest that oxytocin-induced improvement of facial 
emotion recognition is independent of modulations in overt visual attention. 
Keywords: oxytocin, facial emotion recognition, social cognition, emotion, eye-
tracking, visual attention 
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Introduction 
The neuropeptide oxytocin (OXT) is well known for its fundamental role in the 
regulation of social behavior and social cognition in humans (Heinrichs, von Dawans, & 
Domes, 2009). Considering that the ability to decode another’s facial expression is a 
prerequisite for social interaction, it is not surprisingly that OXT improves the recognition of 
emotional expressions in static (Di Simplicio, Massey-Chase, Cowen, & Harmer, 2009; 
Domes, Heinrichs, Michel, Berger, & Herpertz, 2007; Guastella et al., 2010; Marsh, Yu, Pine, 
& Blair, 2010; Schulze et al., 2011) and dynamic (Fischer-Shofty, Shamay-Tsoory, Harari, & 
Levkovitz, 2010) faces; although it remains inconclusive whether emotion recognition is 
specifically improved for positive (Di Simplicio, et al., 2009; Marsh, et al., 2010; Schulze, et 
al., 2011) or negative (Fischer-Shofty, et al., 2010) expressions. Other studies have shown 
that an enhanced exploration of the eye region is likely to improve emotion recognition 
because the eye region conveys the most relevant cues for emotion recognition (Schyns, 
Bonnar, & Gosselin, 2002; Schyns, Petro, & Smith, 2007, 2009; Smith, Cottrell, Gosselin, & 
Schyns, 2005). Based on this, it seems possible that OXT might improve emotion recognition 
by directing visual attention to the eye region. Although the proposed mediating effect of 
visual attention for OXT effects on emotion recognition has not been explicitly tested yet, it 
has been shown that OXT increases gaze to the eye region of neutral (Andari et al., 2010; 
Guastella, Mitchell, & Dadds, 2008) and emotional (Gamer, Zurowski, & Buchel, 2010) 
expressions and that OXT enhances the ability to infer an opponent’s mental state from subtle 
cues around the eye region (Domes, et al., 2007; Guastella, et al., 2010). Regarding the neural 
mechanisms underlying OXT effects on visual attention during emotion recognition, recent 
studies have demonstrated that the amygdala and superior colliculi are involved in directing 
visual attention to the eye region of faces (Adolphs & Spezio, 2006; Gamer & Buchel, 2009). 
Moreover, OXT effects on visual attention and emotion recognition have been shown to be 
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mediated by the amygdala and superior colliculi (Gamer, et al., 2010). 
Encouraged by these findings, we assessed overt visual attention using eye-tracking 
during a dynamic emotion recognition task in order to investigate whether visual attention 
mediates the effects of OXT on emotion recognition. We hypothesized that OXT would 
generally promote emotion recognition from dynamically changing expressions and that OXT 
would direct visual attention to the eye region of these expressions. In addition, we expected a 
positive association between emotion recognition performance and visual attention for the eye 
region. 
Materials and methods 
Participants 
In a double-blind, placebo-controlled between-subjects design, 47 healthy males [age: 
M = 26.09, SD = 3.41] were randomly assigned to receive a nasal spray either containing 24 
international units (IU) of OXT (n = 23; Syntocinon, Novartis, Basel, Switzerland) or placebo 
(PLC; containing all ingredients except for the neuropeptide; n = 24). Randomization was 
done by the compounding pharmacist. There were no differences between the groups in age, 
general intelligence, empathy, alexithmyia or psychopathology [all Fs < 2.72, all ps > .11; see 
Table S1]. Exclusion criteria for all participants were physical or mental illness, use of 
medication, substance abuse and smoking. All participants provided written, informed 
consent and were paid for participation. The study was carried out in accordance with the 
Declaration of Helsinki and was approved by the ethical committee of the University of 
Rostock. 
Experimental procedure 
Following a standardized protocol (Domes et al., 2010), participants self-administered 
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the nasal spray (three puffs per nostril, each containing 4 IU of OXT or PLC) 45 min before 
the start of the emotion recognition task (Born et al., 2002). Substance-induced changes in 
mood, calmness and wakefulness were tracked by administering a multidimensional mood 
questionnaire (Multidimensionaler Befindlichkeitsbogen, MDBF; Steyer, Schwenkmezger, 
Notz, & Eid, 1997) directly before substance application and directly before the emotion 
recognition task. After the experimental session, self-report revealed that participants were not 
able to discriminate OXT and PLC. In addition, participants did not report any side-effects 
following substance application. 
After arrival at the laboratory, a venous catheter was inserted into the participant’s 
forearm. Following a 30 minute catheter habituation period, blood samples were drawn 5 min 
before and 45 min after substance application into 5 ml EDTA vacutainer tubes to control for 
differences in OXT resorption. Immediately after collection, the samples were cooled in ice-
chilled water at 4° C, 15 min later centrifuged at 4000 rpm (for 5 min at 4° C) and finally 
stored in a freezer at -20° C. After completion of the study, the samples were shipped on dry 
ice at -20° C to the Department of Behavioral and Molecular Neuroendocrinology at the 
University of Regensburg, Germany, where they were extracted and analyzed using a 
radioimmunoassay (Landgraf, 1981). The assay detection limit was 0.1 pg/sample, cross-
reactivity with other related neuropeptides was < 0.7%, intra-assay precision was 7-10% and 
inter-assay variability was eliminated by measuring all samples within the same assay. 
Experimental task 
Forty-five min after substance application, participants performed the emotion 
recognition task. The task involved the use of computer-manipulated images of faces, whose 
neutral expression was gradually and continuously changing into an emotional one (see 
Domes et al., 2008). The images were selected on basis of a validation study from the FACES 
database (Ebner, Riediger, & Lindenberger, 2010) and consisted of six young male and six 
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young female individuals, each depicting a neutral, happy, angry, fearful and sad expression. 
Adobe Photoshop CS4 (Adobe Systems Inc., San Jose, CA, USA) and Matlab 7.7 
(MathWorks Inc., Natick, MA, USA) were used to convert the images into grayscales and to 
equalize them in size and cumulative brightness. Thereafter, each image was enclosed within 
an elliptic mask (411 x 570 pixels) that only revealed the face itself. Winmorph 3.01 
(http://www.debugmode.com/winmorph/) was used to morph each emotional expression with 
a neutral expression in 5% increments, resulting in expressions varying in emotional intensity 
from 0% (neutral) to 100% (emotional). For each individual face four sets of images (happy, 
angry, fearful and sad expressions) were obtained, each containing 21 images. Each image of 
a set of expressions was presented for 800 ms, ranging from 0% to 100% of intensity. Each 
image was presented on a 20” computer screen (screen size: 30.6 cm x 40.8 cm; resolution: 
1024 x 768 pixels) against a gray background at a viewing distance of 55 cm 
(vertical/horizontal visual angle of approx. 17°/23.5°). 
Participants were instructed to press a stop button as soon as they recognized the 
expression of the face. After stopping the presentation, the face remained visible on screen 
and participants had to identify the particular expression by making a forced-choice between 
four possible emotion labels (happy, angry, fearful, sad). No time limit was given for the 
choice of the emotion label. The intensity level at which the expression was detected and the 
label that was chosen to identify this expression were used for statistical analyses. Of note, 
only correctly recognized expressions were considered in the analyses involving data from the 
emotion recognition task (intensity levels, number of recognized expressions). 
Eye-tracking 
During the emotion recognition task, participants’ eye movements were recorded with 
a remote infra-red eye-tracker with a chin-rest (Viewpoint PC-60 Head Fixed; Arrington 
Research Inc., Scottsdale, AZ, USA). Raw data were collected at a 60 Hz sampling rate with a 
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spatial resolution of approx. 0.15° and 0.25°-1.0° for gaze position accuracy.  
Algorithms implemented in ILAB (Gitelman, 2002) were used for the analysis of the 
eye-tracking data. After smoothing of the raw data with a Gaussian filter, blink and artifact 
detection was performed. Three participants of the OXT group and one participant of the PLC 
group had to be excluded from the analysis because of more than 20% lost data. There were 
no differences between the remaining groups with regard to valid data [all Fs < 1.86, all ps > 
.15]. Fixations were coded when gaze remained for at least 100 ms within an area with a 
diameter of 1°. Image-specific templates were used to specify regions covering the whole face 
(elliptic template: 411 x 570 pixels), the eyes (rectangular template: 354 x 123 pixels) and the 
mouth (rectangular template: 223 x 87 pixels). For each trial, we calculated the mean duration 
of fixations to the whole face relative to the screen, to the eye region relative to the whole face 
and to the mouth region relative to the whole face. In order to investigate the initial allocation 
of visual attention, we also calculated the mean fixation duration for these regions of interest 
for the first 1600 ms of each trial. 
Statistical analyses 
All statistical analyses were performed using SPSS 15 (IBM SPSS Inc., Chicago, IL, 
USA). OXT effects on mental state and emotion recognition were analyzed with two-way 
repeated measures ANOVAs, while OXT effects on visual attention were analyzed with two- 
and three-way repeated measures ANOVAs. For all repeated measures ANOVAs, the 
Greenhouse-Geisser correction was applied to correct for potential violations of the sphericity 
assumption. Post-hoc analyses of significant main effects and interactions involved t tests and 
two-way ANOVAs, respectively. Multiple moderated regression analyses were performed to 
test for the mediating effect of OXT on the association between emotion recognition 
performance and visual attention for the eye region. The level of significance for all analyses 
was set at p < .05. In case of significant effects, the effect size measure f was reported 
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according to Cohen (Cohen, 1988). 
Results 
Substance application 
To test whether participants of the OXT and PLC group differed in peripheral OXT 
levels (in pg/ml) over the time course of substance application (see Table S2), a two-way 
repeated measures ANOVA (Group x Time) was run [main effect of time: F(1,45)= 2.46, p = 
.12; main effect of group: F(1,45) = 3.79, p = .06; time by group interaction: F(1,45) = 26.94, 
p < .001, f = 0.76]. OXT administration resulted in a significant increase in peripheral OXT 
levels [pre: M = 24.6, SD = 19.0; post: M = 39.7, SD = 20.1], whereas PLC administration had 
no such effect [pre: M = 27.2, SD = 16.6; post: M = 22.8, SD = 16.8]. 
Further two-way repeated measures ANOVA (Group x Time) were performed to test 
for changes in participants’ mental state throughout substance application (see Table S2). 
Participants’ mood [main effect of time: F(1,45) = 2.49, p = .12; main effect of group: F(1,45) 
= 1.78, p = .19; group by time interaction: F(1,45) = 3.02, p = .09] and calmness [main effect 
of time: F(1,45) = 1.31, p = .26; main effect of group: F(1,45) = 0.32, p = .86; group by time 
interaction: F(1,45) = 0.03, p = .86] were unaffected by time and substance application. The 
trend towards a group by time interaction for participants’ mood was due to slightly lower 
post-application mood in the OXT than PLC group [PLC: M = 4.5, SD = 0.4; OXT: M = 4.2, 
SD = 0.6; t(45) = 1.92; p = .07]. Although participants’ wakefulness declined throughout 
substance application, this decline was observed in both groups, ruling out that this was due to 
OXT administration [main effect of time: F(1,45) = 38.94, p < .001, f = 0.92; main effect of 
group: F(1,45) = 1.55, p = .22; group by time interaction: F(1,45) = 0.09, p = .77]. 
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Emotion recognition 
A two-way repeated measures ANOVA (Group x Emotion) demonstrated that OXT 
administration decreased intensity levels at which the expressions were correctly recognized 
[PLC: M = 44.2, SD = 8.2; OXT: M = 39.1, SD = 7.6; see Figure 1A and Table S1], regardless 
of the particular type of emotion [main effect of group: F(1,45) = 4.86, p = .03, f = 0.32; 
group by emotion interaction: F(1,135) = 1.32, p = .27]. In general, participants’ recognition 
thresholds were low for happy expressions, moderate for angry and fearful expressions and 
high for sad expressions [main effect emotion: F(3,135) = 77.30, p < .001, f = 1.31]. 
Exploratory follow-up analyses suggested that OXT specifically lowered participants’ 
recognition thresholds for angry [t(45) = 2.67, p < .01, d = 0.76; see Figure 1A and Table S3] 
and fearful [t(45) = 2.01, p = .05, d = 0.59; see Figure 1A and Table S3] expressions, while 
leaving recognition thresholds for the other expressions unaffected [all ts < 1.6, all ps > .12; 
see Figure 1A and Table S3]. 
Another two-way repeated measures ANOVA (Group x Emotion) indicated that OXT 
administration had no effect on participants’ recognition accuracy [main effect of group: 
F(1,45) = 0.29, p = .59; group by emotion interaction: F(2.25,101.23) = 1.54, ε = .75, p = 
.22], which was generally high for happy expressions, moderate for angry and fearful 
expressions and low for sad expressions [main effect of emotion: F(2.25,101.23) = 38.46, ε = 
.75, p < .001, f = 0.92]. Exploratory follow-up analyses suggested that OXT specifically 
enhanced participants’ recognition accuracy for fearful [t(45) = 2.36, p = .02; see Figure 1B 
and Table S3] but not for the other [all ts < 0.60, all ps > .55; see Figure 1B and Table S3] 
expressions. 
[Insert Table 1 and Figure 1 about here] 
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Visual attention 
Initial allocation of visual attention to facial regions 
A two-way repeated measures ANOVA (Group x Emotion) showed that OXT 
administration had no effect on the duration of fixations that were initially directed to the face 
[main effect of group: F(1,41) = 0.16, p = .69; main effect of emotion: F(2.06,84.36) = 2.21, ε 
= .69, p = .12; group by emotion interaction: F(2.06,84.36) = 1.11, ε = .69, p = .34; see Table 
1]. A subsequent three-way repeated measures ANOVA (Group x Emotion x Region) 
revealed that the duration of initial fixations to the eye or mouth region was also unaffected 
by OXT administration [main effect of group: F(1,41) = 0.18, p = .67; group by emotion 
interaction: F(2.38,97.63) = 1.18, ε = .79, p = .32; group by emotion by region interaction: 
F(2.42,91.931) = 1.26, ε = .75, p = .29; see Table 1]. 
Overall allocation of visual attention to facial regions 
A two-way repeated measures ANOVA demonstrated that OXT administration had no 
effect on the overall duration of fixations that were directed to the face [main effect of group: 
F(1,41) = 0.10, p = .75; main effect of emotion: F(1.96,80.19) = 0.24, ε = .65, p =. 78; group 
by emotion interaction: F(1.96,80.19) = 0.78, ε = .65, p = .46; see Table 2]. Another three-
way repeated measures ANOVA (Group x Emotion x Region) revealed that the overall 
duration of fixations to the eye or mouth region was also unaffected by OXT administration 
[main effect of group: F(1,41) = 0.16, p = .70; group by emotion interaction: F(3,123) = 0.76, 
p = .52; group by emotion by region interaction: F(3,123) = 0.58, p = .63; see Table 2]. 
Association between visual attention to the eye region and emotion recognition 
Separate multiple regression analyses were performed to test whether OXT improved 
emotion recognition by directing gaze to the eye region of the different emotional 
expressions. OXT administration moderated the association between the overall duration of 
fixations to the eye region of sad expressions and the corresponding intensity levels at which 
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these expressions were correctly recognized [t(144) = -2.14 , p = .04; see Figure 2]: In the 
OXT group there was an association between eye gaze and recognition thresholds for sad 
expressions [r(23) = -.52, p = .02], whereas such an association was absent in the PLC group 
[r(23) = .03, p = .90]. No such moderation was found when considering the number of 
correctly recognized expressions in these analyses. 
[Insert Figure 2 about here] 
Discussion 
The first aim of the present study focused on the effects of intranasal OXT on emotion 
recognition from dynamic facial expressions. In the present study, OXT decreased the critical 
intensity at which participants were able to recognize the emotional expressions. In other 
words, participants of the OXT group, relative to those of the PLC group, were able to 
correctly recognize all emotional expressions at lower intensity levels, which seemed to be 
particularly pronounced during the processing of angry and fearful expressions. This effect 
was not due to more liberal responding, i.e., participants of the OXT group did not respond 
earlier during the presentation of the dynamic expressions for the price of lower accuracy. 
Accuracy in general was quite high in the present study and participants of the OXT group 
tended to make even fewer errors for the fearful expressions than participants of the PLC 
group, which is in line with previous studies (Fischer-Shofty, et al., 2010). In contrast to 
previous studies which suggested specific effects of OXT on the recognition of positive (Di 
Simplicio, et al., 2009; Marsh, et al., 2010) or negative (Fischer-Shofty, et al., 2010) 
expressions, the present study supports a more general view: OXT seems to enhance emotion 
recognition from dynamic facial expressions irrespective of the expressions’ emotional 
valence, although the effect was marginally larger for angry and fearful than any other 
expression. Differences in task sensitivity might in part explain the divergent results. In 
Appendix A    67 
 
contrast to previous studies that used static emotion recognition tasks (Di Simplicio, et al., 
2009; Domes, et al., 2007; Marsh, et al., 2010), the present study used a dynamic emotion 
recognition task that mainly relied on recognition thresholds rather than on error rates. Hence, 
differences in item difficulty might have been less relevant in the present as compared to 
previous studies. For example, previous studies have shown that the same task might differ in 
the sensitivity to detect subtle effects of OXT in different samples (Domes, et al., 2007; 
Guastella, et al., 2010). Another possible explanation might be differences in the facial stimuli 
that have been used in these studies. Fisher-Shofty and colleagues (Fischer-Shofty, et al., 
2010), for example, presented the eye region of faces and found a specific effect of OXT on 
recognition accuracy for fearful expressions. We, in contrast, presented whole faces to 
investigate the role of visual attention for different regions of the face during emotion 
recognition and found that OXT had a general effect on recognition thresholds for all 
expressions in addition to a specific effect on recognition accuracy for fearful expressions. 
The eye region seems to play a crucial role in the recognition of fear and thus might have 
been the most sensitive emotional category in the previous study (Fischer-Shofty, et al., 
2010). Moreover, since OXT has been found to improve memory for facial expressions 
(Guastella, Mitchell, & Mathews, 2008; Rimmele, Hediger, Heinrichs, & Klaver, 2009), it 
could have been possible that OXT enhanced memory for prototypical facial expressions in 
the present study, thereby enhancing emotion recognition by improving the matching between 
the presented and previously memorized expressions. 
The second aim of the present study was to test whether OXT promotes emotion 
recognition by enhancing overt visual attention for the eye region of emotional expressions. In 
all, there was no effect of OXT on the duration of fixations that were directed to the face itself 
or to distinct regions of the face. The lack of an OXT effect on visual attention contradicts 
previous studies which suggested that OXT promotes eye gaze during face processing 
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(Andari, et al., 2010; Gamer, et al., 2010; Guastella, Mitchell, & Dadds, 2008). Differences in 
stimulus presentation could explain the disparity of findings. In contrast to previous studies, 
which presented static faces with neutral (Guastella, Mitchell, & Dadds, 2008) and emotional 
(Andari, et al., 2010) expressions for normal durations or static faces with emotional 
expressions for very short durations (Gamer, et al., 2010), we used dynamic faces, which 
introduce the aspect of increasing emotional intensity over the time course of stimulus 
presentation. In addition, the presentation time of the facial expressions was on average much 
longer in the present than in the previous studies (Andari, et al., 2010; Gamer, et al., 2010; 
Guastella, Mitchell, & Dadds, 2008). In static faces, the eyes might be especially salient 
because they convey crucial information about an individual’s emotional state (Emery, 2000) 
and attention might be captured by the eyes because they are assumed to be the most 
informative part of the face (Adolphs, Baron-Cohen, & Tranel, 2002). OXT might be 
especially involved in the initial allocation of attentional resources during face processing. 
This interpretation is in line with the above mentioned study by Gamer and colleagues 
(Gamer, et al., 2010), who showed reflexive saccades towards the eyes even for facial 
expressions that were only presented for 150 ms. In dynamic faces, the effect of OXT on the 
initial orienting probably becomes less relevant with increasing presentation times of the 
faces. OXT might, thus, facilitate eye gaze during the processing of static rather than dynamic 
faces, in particular when the faces are briefly presented. It should be noted, however, that 
there was a moderate association between eye gaze and recognition sensitivity during the 
processing of sad expressions in the OXT group.  
In light of the limited sample size, the statistical power is too low to draw definite 
conclusions. Using more sensitive measures of emotion recognition and/or more fine-grained 
eye-tracking methods might be a promising approach to investigate the association between 
visual attention and emotion recognition and its modulation by OXT. Future studies could 
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additionally investigate whether the changing features of dynamic facial expressions modulate 
visual attention over time and whether OXT modulates attentional capture by these changing 
features. Another limitation is the fact that we excluded female participants from the study. 
Future studies could explicitly investigate the sexual dimorphism of OXT effects in the 
central nervous system as suggested by previous studies (Carter, 2007; Domes, et al., 2010). 
In sum, this is the first study that explicitly investigated the possible role of visual 
attention for the effect of OXT on facial emotion recognition. Consistent with previous 
studies showing positive effects of OXT on face processing (Di Simplicio, et al., 2009; 
Domes, et al., 2007; Fischer-Shofty, et al., 2010; Guastella, et al., 2010; Guastella, Mitchell, 
& Mathews, 2008; Marsh, et al., 2010; Rimmele, et al., 2009; Schulze, et al., 2011), the 
present study suggests that OXT promotes emotion recognition from dynamic facial 
expressions, which resemble a more naturalistic interpersonal situation than static facial 
expressions. With regard to the role of visual attention as a possible mediating factor, the 
present findings suggest that the positive effect of OXT on emotion recognition might be 
independent of modulations of visual attention to specific facial regions, at least during the 
processing of the dynamic facial expressions. 
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Tables 
Table 1 
Visual attention during the initial 1600 ms of a trial 
 Placebo 
(n = 24) 
 Oxytocin 
(n = 20)a 
 M SD  M SD 
Happy expressions      
 Face/Screen .95 .16  .99 .03 
 Eye/Face .64 .24  .75 .19 
 Mouth/Face .02 .08  .01 .03 
Angry expressions      
 Face/Screen 1.00 .00  1.00 .00 
 Eye/Face .75 .14  .72 .15 
 Mouth/Face .01 .03  .00 .00 
Sad expressions      
 Face/Screen .94 .18  .96 .08 
 Eye/Face .69 .23  .69 .20 
 Mouth/Face .01 .06  .01 .03 
Fearful expressions      
 Face/Screen 1.00 .02  .97 .08 
 Eye/Face .66 .20  .66 .18 
 Mouth/Face .01 .02  .01 .04 
Note. aData from three participants of the oxytocin group and one participant of the placebo group were excluded 
because of massive blink artifacts. 
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Table 2 
Visual attention during the whole trial 
 Placebo 
(n = 24) 
 Oxytocin 
(n = 20)a 
 M SD  M SD 
Happy expressions      
 Face/Screen .96 .14  .97 .04 
 Eye/Face .44 .15  .50 .16 
 Mouth/Face .26 .12  .23 .14 
Angry expressions      
 Face/Screen .96 .08  .99 .03 
 Eye/Face .59 .20  .66 .16 
 Mouth/Face .13 .10  .09 .07 
Sad expressions      
 Face/Screen .96 .08  .97 .08 
 Eye/Face .60 .20  .63 .14 
 Mouth/Face .12 .08  .10 .08 
Fearful expressions      
 Face/Screen .98 .04  .96 .07 
 Eye/Face .62 .16  .63 .15 
 Mouth/Face .15 .09  .11 .09 
Note. aData from three participants of the oxytocin group and one participant of the placebo group were excluded 
because of massive blink artifacts. 
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Figures 
 
Figure 1. (A) Intensity levels and (B) number of correctly recognized emotional expressions. 
Asterisks indicate significant post-hoc single comparisons (p < .05, two-tailed). Bars represent 
mean and standard error of the mean in percent. 
 
 
  
Appendix A    77 
 
 
Figure 2. Linear association between overall duration of fixations to the eye region and 
intensity levels at which sad expressions were correctly recognized. Lines represent linear 
regression curves for the oxytocin and the placebo group. 
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Supplemental material 
Table S1 
Group differences in demographical and psychopathological measures 
 Placebo 
(n = 24) 
 Oxytocin 
(n = 23) 
 Test statistic 
 M SD  M SD  F(df) p 
Age 26.38 3.49  25.78 3.37  F(1,45) = 0.35 .56 
General intelligence (WST) 33.58 1.41  33.74 1.82  F(1,45) = 0.11 .74 
General psychopathology (SCL-90-R-GSI) 0.11 0.10  0.21 0.26  F(1,45) = 2.73 .11 
Anxiety (STAI-T) 31.54 5.38  32.52 6.47  F(1,45) = 0.32 .58 
Anger (STAXI-T) 15.75 3.34  17.26 4.98  F(1,45) = 1.50 .23 
Positive affect (PANAS-T) 36.00 3.28  36.13 3.88  F(1,45) = 0.02 .90 
Negative affect (PANAS-T) 16.08 4.27  16.61 4.50  F(1,45) = 0.17 .68 
Alexithymia (TAS-20) 39.71 8.30  41.70 10.15  F(1,45) = 0.54 .47 
Empathy (IRI) 66.83 8.38  65.70 8.40  F(1,45) = 0.22 .64 
Note. IRI = Interpersonal Reactivity Index (Davis, 1983); PANAS-T = Positive and Negative Affect Scale - Trait 
Positive and Negative Affect (Watson, Clark, & Tellegen, 1988); SCL-90-R-GSI = Symptom Checklist-90-
Revised - Global Severity Index (Franke, 1995); STAI-T = State Trait Anxiety Inventory - Trait Anxiety (Laux, 
Glanzmann, Schaffner, & Spielberger, 1981); STAXI-T = State Trait Anger Expression Inventory - Trait Anger 
(Spielberger, 1991); TAS-20 = Twenty-item Toronto Alexithymia Scale (Bagby, Parker, & Taylor, 1994; Bagby, 
Taylor, & Parker, 1994); WST = Wortschatztest (Schmidt & Metzler, 1992). 
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Table S2 
Group differences in peripheral oxytocin levels and mental state 
 Placebo 
(n = 24) 
 Oxytocin 
(n = 23) 
 Test statistic 
 M SD  M SD  t(df) p 
Peripheral oxytocin levels (pg/ml)         
 Pre-application 27.18 16.61  24.63 18.97  t(45) = .49 .63 
 Post-application 22.83 16.91  39.70 20.12  t(45) = -4.05 <.001*** 
Mood (MDBF)         
 Pre-application  4.48 0.47  4.42 0.47  t(45) = 0.40 .69 
 Post-application 4.49 0.38  4.21 0.61  t(45) = 1.92 .07 
Calmness (MDBF)         
 Pre-application 4.25 0.65  4.21 0.57  t(45) = 0.25 .36 
 Post-application 4.35 0.60  4.35 0.58  t(45) = 0.04 .97 
Wakefulness (MDBF)         
 Pre-application 3.94 0.72  3.74 0.74  t(45) = 0.93 .81 
 Post-application 3.18 0.84  2.90 0.84  t(45) = 1.13 .27 
Note. MDBF = Multidimensonaler Befindlichkeitsfragebogen (Steyer, Schwenkmezger, Notz, & Eid, 1997). 
***p < .001, two-sided. 
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Table S3 
Group differences in recognition sensitivity and recognition accuracy 
 Placebo 
(n = 24) 
 Oxytocin 
(n = 23) 
 M SD  M SD 
Recognition thresholds      
 Happy expressions 35.50 8.47  31.92 6.72 
 Angry expressions 43.81 10.03  36.20 9.45 
 Sad expressions 51.99 10.20  47.67 10.77 
 Fearful expressions 45.64 9.22  40.70 7.50 
Recognition accuracyb      
 Happy expressions 11.92 0.28  11.91 0.29 
 Angry expressions 10.96 1.12  10.74 1.39 
 Sad expressions 9.54 1.74  9.48 1.50 
 Fearful expressions 10.83 1.13  11.52 0.85 
Note. aIntensity levels of correctly recognized expressions (in percent). bNumber of correctly recognized 
expressions (in percent). 
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Abstract 
To investigate the mechanisms by which oxytocin improves socio-affective 
processing, we assessed behavioral and pupillometric measures during a dynamic facial 
emotion recognition task. In a double-blind, between-subjects design, 47 healthy males 
received either 24 IU intranasal oxytocin or placebo. Participants of the oxytocin group 
recognized all facial expressions at lower intensity levels than participants of the placebo 
group. Improved performance in the oxytocin group was associated with greater task-related 
pupil dilation, indicating increased recruitment of attentional resources. In addition, we found 
that the female gender-specific stimulus effect diminished in the oxytocin group, in which 
pupil size was increased for male faces. In sum, our data suggest that improved emotion 
recognition after oxytocin administration might be due to increased stimulus processing. 
Oxytocin thereby enhances the salience of stimuli which usually do not recruit much 
attention. 
Keywords: pupillary responses, oxytocin, facial emotion recognition, gender, social 
cognition 
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Introduction 
The neuropeptide oxytocin (OXT) has been found to play a key role in the regulation 
of social behavior (Bartz, Zaki, Bolger, & Ochsner, 2011; Guastella & MacLeod, 2012; 
Heinrichs, von Dawans, & Domes, 2009; Meyer-Lindenberg, Domes, Kirsch, & Heinrichs, 
2011). OXT is synthesized in the hypothalamus and released into both, the brain and the 
bloodstream. Apart from its well-known functions in reproduction, such as stimulating uterine 
contraction during labor and milk ejection, OXT also acts as a neuromodulator with receptors 
widely distributed in the brain, including the limbic-hypothalamic system, midbrain regions 
and the brain stem (Landgraf & Neumann, 2004). Since neuropeptides cross the blood-brain 
barrier after intranasal administration (Born et al., 2002), a number of studies has been 
conducted in humans demonstrating, for instance, that OXT promotes prosocial behavior, 
affiliation and trust (e.g., Baumgartner, Heinrichs, Vonlanthen, Fischbacher, & Fehr, 2008; 
Kosfeld, Heinrichs, Zak, Fischbacher, & Fehr, 2005), improves social recognition and 
memory (e.g., Guastella, Mitchell, & Mathews, 2008; Rimmele, Hediger, Heinrichs, & 
Klaver, 2009; Unkelbach, Guastella, & Forgas, 2008) and attenuates social stress and anxiety 
(e.g., Heinrichs, Baumgartner, Kirschbaum, & Ehlert, 2003; Linnen, Ellenbogen, Cardoso, & 
Joober, 2012). 
As a prerequisite for social cognition, intranasally administered OXT has been 
consistently found to improve the ability to decode mental and affective state of others’ from 
facial expressions (Di Simplicio, Massey-Chase, Cowen, & Harmer, 2009; Domes, Heinrichs, 
Michel, Berger, & Herpertz, 2007; Fischer-Shofty, Shamay-Tsoory, Harari, & Levkovitz, 
2010; Lischke, Berger, et al., 2012; Marsh, Yu, Pine, & Blair, 2010; Schulze et al., 2011). It 
has been argued that improved emotion recognition might be due to an enhanced exploration 
of the eye region during face processing (Andari et al., 2010; Domes, Heinrichs, Michel, et 
al., 2007; Guastella et al., 2010; Guastella, Mitchell, & Dadds, 2008). Directly investigating 
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this hypothesis using eye-tracking and a dynamic facial emotion recognition task, Lischke and 
colleagues (Lischke, Berger, et al., 2012) recently replicated the effect of enhanced emotion 
recognition but did not find any OXT-induced alterations in the visual scanning of the faces. 
In this study, we aimed to further investigate the mechanisms by which OXT might 
improve the exploration and recognition of socio-affective stimuli by analyzing pupillometric 
data during the same dynamic facial emotion recognition task. Pupillometric data, such as 
pupil diameter, can be used as a sensitive and reliable indicator for cognitive resource 
consumption. Pupil diameter is controlled by two muscles that are innervated by the 
sympathetic and parasympathetic branches of the autonomic nervous system, which get their 
input from brain structures essential for both, affective and cognitive information processing. 
Increased sympathetic activity increases the activity of the dilator muscle, leading to pupil 
dilation, whereas decreased parasympathetic activity decreases the activity of the sphincter 
muscle, which also results in a dilation of the pupil (for a more detailed description of the 
neural basis of pupillary responses see Hoeks & Ellenbroek, 1993; Steinhauer & Hakerem, 
1992). Although increases in pupil diameter can be regulated by either branch of the 
autonomic nervous system, they are mainly regulated by the parasympathetic branch, whose 
activity is modulated by the locus coeruleus (Steinhauer, Siegle, Condray, & Pless, 2004).  
While tonic changes in pupil diameter reflect the sensitivity of the cognitive system in 
general ("exploration mode"; see Aston-Jones & Cohen, 2005; van der Meer et al., 2010), 
phasic changes have been proven to indicate a stimulus-specific and task-related processing 
load, with larger pupil dilation reflecting greater processing demands (Beatty, 1982; 
Loewenfeld, 1993; Steinhauer & Hakerem, 1992). During a digit span recall task, for 
instance, pupil diameter increases proportionally as a function of the number of digits that 
have to be maintained in short-term memory – until individuals reach their limit of available 
cognitive resources (Granholm, Asarnow, Sarkin, & Dykes, 1996; Kahneman & Beatty, 
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1966). Notably, Just and colleagues (Just, Carpenter, & Miyake, 2003) have demonstrated 
that pupillary responses reflect an overall aggregate of attentional resource allocation that is 
not limited to a specific part of the cognitive system. Peak dilation has been found to increase 
with enhanced processing demand in studies investigating a variety of tasks, comprising 
language comprehension (e.g., Hyona, Tommola, & Alaja, 1995; Just & Carpenter, 1993), 
auditory and visual attention (e.g., Karatekin, Couperus, & Marcus, 2004; Kim, Beversdorf, & 
Heilman, 2000), reasoning and semantic elaboration (e.g., van der Meer, et al., 2010; van der 
Meer, Friedrich, Nuthmann, Stelzel, & Kuchinke, 2003) or emotional valence identification 
(e.g., Prehn et al., 2008; Prehn, Heekeren, & van der Meer, 2011; Siegle, Granholm, Ingram, 
& Matt, 2001; Siegle, Steinhauer, Carter, Ramel, & Thase, 2003). With regard to the 
processing of visual stimuli with emotional content, very early pupillometric studies have 
shown an increase in pupil size when people view pleasant and attention-demanding pictures, 
such as pictures of a baby, a mother holding her child, a partially nude male or female (e.g., 
Hess & Polt, 1960). Later studies showed that pupil size co-varies with the emotional arousal 
rather than with the hedonic valence of the pictures (e.g., Bradley, Miccoli, Escrig, & Lang, 
2008). Recently, Leknes and colleagues (Leknes et al., 2012) provided first evidence that 
OXT administration leads to greater stimulus-induced pupil dilation during the identification 
of subtle and hidden emotional expressions. In that study, participants with lower emotional 
sensitivity and poorer baseline performance showed greater OXT-induced improvement in 
addition to larger task-related pupil dilation. 
In summary, pupillometric studies support the view that pupil size represents a general 
index of attentional resource allocation and that pupil size reflects whether stimuli are 
cognitively engaging or emotionally salient. Following these studies and a first study on the 
effects of OXT on task-related pupillary responses during face processing, we hypothesized 
that improved emotion recognition after OXT administration will be accompanied by 
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increased resource consumption (greater “mental work”) as indicated by greater pupil 
dilation. Given that male and female face stimuli are differently appealing for males, we 
further expected that OXT will affect pupil dilation differentially during the processing of 
male as compared to female faces. 
Materials and methods 
Participants 
In a double-blind, placebo-controlled between-subjects design, 47 healthy males were 
randomly assigned to receive a nasal spray either containing 24 international units (IU)1 of 
OXT (n = 23; Syntocinon, Novartis, Basel, Switzerland) or placebo (PLC; containing all 
ingredients except for the neuropeptide; n = 24). All participants were non-smokers, did not 
report a current or previous neurological, endocrinological or psychiatric disease and did not 
take any medication that could have influenced pupillary responses. Participants reported no 
ophthalmologic problems other than correctable eyesight. 
To control for individual differences in general intelligence, empathy, alexithymia and 
psychopathology, participants completed a test battery including a verbal intelligence test 
(WST; Schmidt & Metzler, 1992), the Symptom Checklist-90-Revised (SCL-90-R; Franke, 
1995), the State Trait Anxiety Inventory (STAI; Laux, Glanzmann, Schaffner, & Spielberger, 
1981), the State Trait Anger Expression Inventory (STAXI; Spielberger, 1991), the Positive 
and Negative Affect Scales (PANAS; Watson, Clark, & Tellegen, 1988), the Twenty-item 
Toronto Alexithymia Scale (TAS-20; Bagby, Parker, & Taylor, 1994; Bagby, Taylor, & 
Parker, 1994) and the Interpersonal Reactivity Index (IRI; Davis, 1983). The psychometric 
measures revealed no differences between the participant groups in terms of general 
intelligence, empathy, alexithymia or psychopathology [all Fs < 2.72, all ps > .11]. There 
                                            
1 24 IU is equivalent to approximately 48 μg of the pure neuropeptide. 
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were also no group differences with regard to participants’ age [OXT: M = 25.78, SD = 3.37; 
PLC: M = 26.38, SD = 3.49; F(1,45) = 0.35, p = .56]. 
The study was carried out in accordance with the Declaration of Helsinki and was 
approved by the local ethics committee. All participants gave written informed consent prior 
to investigation and received payment for participation. 
Experimental task 
To investigate the mechanisms by which OXT improves the exploration and 
recognition of socio-affective stimuli, we used a dynamic facial emotion recognition task 
(Domes et al., 2008; Lischke, Berger, et al., 2012). In this task, participants had to look at 
male and female faces gradually and continuously changing from neutral to happy, angry, 
fearful or sad expressions. For this task, we selected four pictures of six young male and six 
young female faces, showing a neutral, happy, angry, fearful and sad expression, from the 
FACES database (Ebner, Riediger, & Lindenberger, 2010). The colored pictures were 
converted into grayscales, equalized in size and cumulative brightness using Adobe 
Photoshop CS4 (Adobe Systems Inc., San Jose, CA, USA) and Matlab 7.7 (The MathWorks 
Inc., Natick, MA, USA). Then, each picture was enclosed within an elliptic mask (411 x 570 
pixels) that only showed the face itself. Finally, we used Winmorph 3.01 
(http://www.debugmode.com/winmorph/) to transform the neutral expressions into all of the 
emotional ones in 5% steps. This procedure resulted in 48 sets of pictures [12 (6 male and 6 
female) faces x 4 emotional expressions], each containing 21 pictures with increasing 
emotional intensity from 0% (neutral) to 100% (emotional). 
A trial of this task started with a black fixation cross appearing for 1 s on a dark gray 
background (baseline phase). Then, the pictures of a set were presented, starting with 0% 
intensity and increasing up to 100% in 5% steps (emotion recognition phase). Each picture 
was presented for 800 ms. Participants were instructed to press a stop button as soon as they 
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recognized the emotional expression the face was beginning to show. Subsequently, 
participants had to identify the emotional expression by making a forced-choice between four 
emotion labels (happy, angry, fearful, sad; forced-choice phase). No time limit was given for 
the choice of the emotion label. During a trial, participants were asked to keep their head still, 
to maintain fixation and to restrict eye blinks, if possible, until the forced-choice phase at the 
end of the trial. 
In total, the task consisted of 48 trials, with six trials for each each of the eight 
experimental conditions (male happy expression, male angry expression, male fearful 
expression, male sad expression, female happy expression, female angry expression, female 
fearful expression, female sad expression). For each condition, we determined the intensity at 
which the expressions were recognized (recognition sensitivity in terms of intensity levels) 
and the proportion of correctly recognized expressions (recognition accuracy in terms of error 
rates)2. 
Experimental procedure 
Following a standardized protocol (Domes et al., 2007; Domes, Heinrichs, Michel, et 
al., 2007; Domes et al., 2010), participants self-administered the nasal spray (three puffs per 
nostril, each containing 4 IU of OXT or PLC) 45 min before the start of the experiment (Born, 
et al., 2002). Self-report after the experiment revealed that participants were not able to 
discriminate whether they had received OXT or PLC. Participants also did not report any 
side-effects following substance administration. 
To control for differences in OXT resorption and as a manipulation check, we inserted 
a venous catheter into the participant’s forearm directly after arrival at the laboratory. 
                                            
2 Of note, a report on participants’ task performance that did not take the gender of the stimulus material into 
account has already been provided by Lischke and colleagues (Lischke, Berger, et al., 2012). 
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Following a 30 min catheter habituation period, blood samples were collected 5 min before 
and 45 min after substance administration (i.e., directly before the start of the experiment). 
Immediately after collection, the samples were cooled in ice-chilled water at 4 °C, 15 min 
later centrifuged at 4000 rpm (for 5 min at 4 °C) and finally stored in a freezer at -20 °C. 
After completion of the study, the plasma was shipped on dry ice at -20 °C to the Department 
of Behavioral and Molecular Neuroendocrinology at the University of Regensburg, Germany, 
where they were extracted and analyzed using a radioimmunoassay (Landgraf, 1981). The 
assay detection limit was 0.1 pg/sample, and cross-reactivity with other related neuropeptides 
was < 0.7%. The coefficient of variation for intra-assay precision was 7-10%, whereas inter-
assay variation was eliminated by measuring all samples within the same assay. 
The experimental session took place in a quiet and slightly dimmed room. Participants 
were seated comfortably in front of a 20” computer screen (resolution: 1024 x 768 pixels) at a 
distance of 55 cm. The picture stimuli were presented in a randomized order using the 
experimental control software Presentation 12.1 (Neurobehavioral Systems, Inc., Albany, CA, 
USA), running on a Microsoft Windows XP operating system. During task performance, we 
measured the intensity levels (showing 5% to 100% of the emotion) at which the emotional 
expressions were correctly recognized as well as the corresponding error rates. To control for 
differences in attentional resource allocation during task performance, we also measured 
pupillary responses and gaze behavior. However, only the pupillary data are reported in this 
study, whereas the gaze data are reported elsewhere (Lischke, Berger, et al., 2012). 
Pupillometry 
Pupillary responses were continuously recorded using the ViewPoint system 
(ViewPoint PC-60 Head Fixed; Arrington Research Inc., Scottsdale, AZ, USA), including an 
infrared light source and a video camera sensitive to infrared light. The ViewPoint system 
samples pupil size in terms of pixels normalized with respect to the camera window (see 
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Table 2, Figure 1 and Figure 2). The system was connected with a presentation computer for 
the transmission of trigger signals that marked the beginning of every trial. The participant’s 
head was placed onto a chin rest above which the camera was positioned, allowing continuous 
tracking of the participant’s right eye during the viewing of the picture sets. Pupil size was 
recorded at 59.5 Hz (i.e., every 17 ms) and with an overall accuracy of 0.03 mm. 
Pupillary responses were only analyzed for correctly answered trials. Cleaning and 
reduction of the pupil data were conducted with Matlab 7.13 (The MathWorks Inc., Natick, 
MA, USA) following standard procedures (e.g., Beatty & Lucero-Wagoner, 2000; Granholm, 
et al., 1996; Prehn, et al., 2008; Prehn, et al., 2011; Verney, Granholm, & Dionisio, 2001). 
The data were smoothed using an un-weighted 20-point moving average filter. Blinks, defined 
as large changes in pupil diameter occurring too rapidly to signify actual pupil dilation or 
constriction, were replaced by linear interpolation. We determined the baseline pupil diameter 
for each trial by averaging pupil diameter 200 ms before the presentation of the first picture of 
a set of expressions. This baseline was subtracted from the respective trial (baseline 
correction; see Table 2 for mean baseline pupil diameter). Finally, stimulus-locked pupillary 
responses for each trial were averaged for each condition and participant (see Table 2 and 
Figure 2 for mean task-related pupil diameter). 
In our particular experimental task, in which we presented bright faces on a darker 
background in a slightly dimmed laboratory, we observed an immediate constriction of the 
pupil at the beginning of each trial; that is, with the presentation of the first picture of a set of 
expressions. After 800 ms, pupil diameter increased again over the course of the trial; that is, 
with the presentation of the subsequent pictures of a set of expressions (see Figure 2 and 
Bradley, et al., 2008). As stated earlier, trials were of variable duration: Each trial ended as 
soon as the participant recognized the emotional expression and pressed the stop button. On 
average (across all conditions and both groups), a trial ended after 7.07 s [range: 1.52-17.76 s; 
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5th percentile: 3.20 s]. To have enough trials for averaging, we only averaged pupillary 
responses across a time window (interval of interest) of 800 ms to 3200 ms following the 
presentation of the first picture of a set of expressions, in which at least 95% of trials were 
included. 
When measuring pupillary responses as an index for cognitive and emotional 
processing, it is important to rule out that changes in pupil diameter are simply due to changes 
in lighting conditions (e.g., differences in illumination of the room or luminance of the 
stimuli). Therefore, we kept illumination in the laboratory constant for all sessions and 
adjusted the cumulative brightness of the pictures to ensure that there were no differences in 
luminance between male and female faces [F(1,10) = 0.23, p = .64] or between faces with 
different emotional expressions [F(3,30) = 0.10, p = .88]. 
Statistical analyses 
All statistical analyses were performed using SPSS 20 (IBM SPSS Inc., Chicago, IL, 
USA). In particular, we tested whether OXT administration had an effect on emotion 
recognition (intensity level at which emotional expressions were correctly identified and the 
corresponding error rates) and pupillary responses (mean pupil diameter) during task 
performance. Moreover, we investigated the effects of emotion category (i.e., whether a 
happy, angry, fearful or sad emotion expression appeared) and gender of the stimulus material 
(i.e., whether a male or female face was presented) on emotion recognition and pupillary 
responses. All analyses on intensity levels, error rates and pupil diameters were run with 
means obtained for each participant and condition. As stated earlier, our design contained 
eight conditions in total (male happy expression, male angry expression, male fearful 
expression, male sad expression, female happy expression, female angry expression, female 
fearful expression, female sad expression) with six trials each. Because error trials were 
excluded prior to the analyses, mean intensity levels and mean pupil diameters for each 
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participant and condition were based on approximately 5.5 trials [M = 5.46, SD = 0.31]. 
All means were subjected to three-way repeated measures analyses of variance 
(ANOVAs) with the factors group (OXT, PLC), emotion (happy, angry, fearful, sad) and 
gender of the stimulus material (male, female). Significant effects were further investigated 
by two-way repeated measures ANOVAs and two-tailed post-hoc t tests. The Greenhouse-
Geisser correction was used whenever the assumption of sphericity was violated [ε < 1.0]. 
The significance level for all analyses was set a p < .05. For significant effects, we report 
partial η2 and Cohen’s d as a measure of effect size.  
Results 
Substance application 
To test whether participants of the OXT and PLC group differed in peripheral OXT 
levels (in pg/ml) over the time course of substance application, a two-way repeated measures 
ANOVA (Group x Time) was run. This analysis revealed a significant group by time 
interaction [F(1,45) = 26.94, p < .001, partial η2 = .37], showing a significant increase in 
peripheral OXT levels in the OXT [pre: M = 24.6, SD = 19.0; post: M = 39.7, SD = 20.1] but 
not in the PLC [pre: M = 27.2, SD = 16.6; post: M = 22.8, SD = 16.8] group throughout 
substance application. 
Emotion recognition 
Recognition sensitivity 
A three-way repeated measures ANOVA (Group x Emotion x Gender) on intensity 
levels revealed that OXT generally decreased intensity levels at which the emotional 
expressions were correctly recognized [main effect of group: F(1,45) = 4.94, p = .031, partial 
η2 = .10], regardless of the emotional valence or the gender of the faces [group by emotion 
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interaction: F(3,135) = 1.24, p = .30, partial η2 = .03; group by gender interaction: F(1,45) = 
0.01, p = .92, partial η2 = .00; group by emotion by gender interaction: F(3,135) = 0.66, p = 
.58, partial η2 = .01]. There was also a main effect of emotion [F(3,135) = 75.40, p < .001, 
partial η2 = .63] but neither a main effect of gender [F(1,45) = 1.80, p = .19, partial η2 = .04] 
nor an emotion by gender interaction [F(3,135) = 0.69, p = .56, partial η2 = .02]. The main 
effect of emotion indicated that the different emotional expressions were recognized at 
different levels of intensity: All participants recognized happy expressions at low, angry and 
fearful expressions at moderate and sad expressions at high intensity levels (see Table 1). 
Although we did not find a group by gender interaction [F(1,45) = 0.01, p = .92, partial η2 = 
.00] or a group by emotion by gender interaction [F(3,135) = 0.66, p = .58, partial η2 = .01], 
we conducted exploratory follow-up analyses to investigate whether OXT differentially 
affected recognition sensitivity for male and female faces. We found that OXT specifically 
lowered the recognition threshold for angry expressions in both, male [t(45) = 2.17, p = .035, 
d = 0.64; see Table 1 and Figure 1A] and female [t(45) = 2.73, p = .009, d = 0.80; see Table 1 
and Figure 1A] faces. A similar effect, albeit only on a trend level, was found for fearful 
expressions in male [t(45) = 1.97, p = .055, d = 0.57; see Table 1 and Figure 1A] and female 
[t(45) = 1.83, p = .074, d = 0.54; see Table 1 and Figure 1A] faces. However, none of these 
effects remained significant after correcting for multiple testing, rendering these results 
preliminary. 
Recognition accuracy 
Error rates ranged from 0 (male faces with happy expressions in both, the OXT and 
PLC group; see Table 1) to 0.30 (male faces with sad expressions in the OXT group; see 
Table 1). A three-way repeated measures ANOVA (Group x Emotion x Gender) on error rates 
showed no effect of OXT on recognition accuracy [main effect of group: F(1,45) = 0.15, p = 
.70, partial η2 = .00]. However, we found a main effect of emotion [F(2.25,101.23) = 34.42, ε 
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= .75, p < .001, partial η2 = .43], a main effect of gender [F(1,45) = 4.41, p = .04, partial η2 = 
.09] and an emotion by gender interaction [F(2.25,101.25) = 14.09, ε = .75, p < .001, partial 
η2 = .24], indicating that participants made more errors during the processing of happy 
expressions in female as compared to male faces and more errors during the processing of 
angry, fearful and sad expressions in male as compared to female faces (see Table 1). We did 
not find a group by gender interaction [F(1,45) = 0.63, p = .431, partial η2 = .01] but a group 
by emotion by gender interaction [F(2.25,101.25) = 6.93, ε = .75, p = .001, partial η2 = .13]. 
Follow-up analyses revealed that OXT specifically enhanced recognition accuracy for fearful 
expressions in female [t(37.87) = 2.14, p = .039, d = 0.64; see Table 1] and, at least on a trend 
level, in male [t(45) = 1.83, p = .075, d = 0.54; see Table 1] faces. A similar trend was found 
during the processing of sad expressions in female [t(45) = 1.95, p = .057, d = 0.57; see Table 
1] and male [t(45) = 1.83, p = .10, d = 0.49; see Table 1] faces. However, these results should 
be regarded as preliminary because none of these effects remained significant after correcting 
for multiple testing. 
[Insert Table 1 and Figure 1 about here] 
Pupillary responses 
Baseline-related pupillary responses 
To rule out any influence of baseline pupil diameter on pupillary responses, especially 
between the OXT and PLC group, baseline pupil diameter was also averaged for each 
experimental condition and participant in an interval of interest (200 ms preceding the 
presentation of the first picture of a set of expressions; see Table 2) and subjected to a three-
way repeated measures ANOVA (Group x Emotion x Gender). We found no main effect of 
group [F(1,45) = 0.52, p = .473, partial η2 = .01], no group by emotion interaction 
[F(2.58,116.01) = 1.60, ε = .86, p = .199, partial η2 = .03], no group by gender interaction 
[F(1,45) = 0.35, p = .556, partial η2 = .01] and no group by emotion by gender interaction 
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[F(2.14,96.44) = 0.51, ε =.71, p = .617, partial η2 = .02], indicating that baseline pupil 
diameter was not affected by OXT application. We further found no main effect of emotion 
[F(2.58,116.01) = 0.75, ε = .86, p = .506, partial η2 = .02], no main effect of gender [F(1,45) = 
0.00, p = .973, partial η2 = .00] and no emotion by gender interaction [F(2.14,96.44) = 0.67, ε 
=.71, p = .526, partial η2 = .02], indicating that neither the emotional valence nor the gender of 
the faces had an impact on baseline pupil diameter. There was, thus, no evidence for an 
influence of baseline pupil diameter on task-related pupil dilation. 
Task-related pupillary responses 
A three-way repeated measures ANOVA (Group x Emotion x Gender) on average 
task-related pupil diameter in the interval of interest (800-3200 ms following the presentation 
of the first picture of a set of expressions) showed that OXT increased pupil diameter 
irrespective of the emotional valence of the faces, at least on a trend level [main effect of 
group: F(1,45) = 4.06, p = .050, partial η2 = .08; group by emotion interaction: F(2.47,110.94) 
= 0.28, ε = .82, p = .804 partial η2 = .01; group by emotion by gender interaction: 
F(2.33,104.88) = 0.21, ε = .77, p = .846, partial η2 = .01]. We also found no main effect of 
emotion [F(2.47,110.94) = 1.10, ε = .82, p = .352] and no emotion by gender interaction 
[F(2.33,104.88) = 1.29, ε = .77, p = .280, partial η2 = .03], indicating that the emotional 
valence of the faces had in general no effect on pupillary responses. There was, however, a 
main effect of gender [F(1,45) = 13.19, p = .001, partial η2 = .23], indicating that pupil 
dilation was generally greater during the processing of female than male faces, as well as a 
group by gender interaction [F(1,45) = 5.36, p = .025, partial η2 = .11]. Follow-up analyses 
revealed that OXT specifically increased pupil diameter for male [t(45) = 2.66, p = .011, d = 
0.78; see Table 2 and Figure 2B] but not female [t(45) = -1.10, p = .279; see Table 2 and 
Figure 2B] faces. Accordingly, there was no significant difference in pupil diameter between 
male and female faces in the OXT [t(22) = -1.02, p = .320; see Table 2 and Figure 2B] but in 
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the PLC [t(23) = -3.93, p = .001, d = 0.80; see Table 2 and Figure 2B] group. Although we 
found no group by emotion interaction [F(2.47,110.94) = 0.28, ε = .82, p = .84 partial η2 = 
.01] or group by emotion by gender interaction [F(2.33,104.88) = 0.21, ε = .77, p = .846, 
partial η2 = .01], we performed exploratory follow-up analyses to further investigate how 
OXT affected pupillary responses to male and female faces with different emotional 
expressions. We found that OXT specifically increased pupil diameter during the processing 
happy [t(45) = -2.46, p = .018, d = 0.72; see Table 2, Figure 1B and Figure 2A] and fearful 
[t(45) = -2.07, p = .044, d = 0.60; see Table 2, Figure 1B and Figure 2A] expressions in male 
faces. A similar effect, albeit only on a trend level, was found for angry [t(45) = -1.78, p = 
.082, d = 0.53; see Table 2, Figure 1B and Figure 2A] and sad [t(45) = -1.70, p = .097, d = 
0.50; see Table 2, Figure 1B and Figure 2A] expressions in male faces as well as for happy 
expressions in female [t(45) = -1.77, p = .084, d = 0.52; see Table 2, Figure 1B and Figure 
2A] faces. However, the results of these follow-up analyses should be treated with caution 
because none of these effects remained significant after correcting for multiple comparisons. 
[Insert Table 2 and Figure 2 about here] 
Discussion 
The aim of the present study was to explore the mechanisms underlying OXT effects 
on the exploration and recognition of socio-affective stimuli. Forty-seven healthy males 
received either OXT or PLC before performing a dynamic emotion recognition task. During 
the emotion recognition task, we measured task performance (intensity levels at which the 
emotional expressions were correctly recognized and the corresponding error rates) as well as 
pupillary responses (changes in pupil diameter). The study yielded three main results: First, 
better emotion recognition in the OXT group was associated with greater pupil dilation (main 
effect of group). Second, we found a difference in pupil diameter during the processing of 
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female as compared to male faces (main effect of gender), reflecting male participants’ lower 
interest in male faces. Third, this female gender-specific stimulus presentation effect was 
diminished in the OXT group, in which pupil size was significantly increased for male faces 
(group by gender interaction). In the following, we argue that indicators of task performance 
(improved emotion recognition) in addition to indicators of attentional resource allocation 
(increased pupil dilation) provide evidence for the view that OXT increases the salience of 
socio-affective stimuli, especially for stimuli that usually do not recruit much attention. 
Indicators of task performance 
After OXT administration, participants recognized the emotional expressions at lower 
intensity levels and made fewer errors, regardless of the specific type of emotional expression 
(see Table 1). This result has already been presented by Lischke and colleagues (Lischke, 
Berger, et al., 2012) and is in line with other studies showing improved recognition of 
emotional and mental states after OXT administration (e.g., Di Simplicio, et al., 2009; Domes, 
Heinrichs, Michel, et al., 2007; Guastella, et al., 2010; Marsh, et al., 2010; Schulze, et al., 
2011). Although we found no effect of the gender of the stimulus material on intensity levels 
(no gender-related main or interaction effects), the gender of the stimulus material affected 
error rates during task performance (main effect of gender, gender by emotion interaction, 
gender by emotion by group interaction), suggesting that male and female faces were 
differentially processed. 
Indicators of attentional resource allocation 
Numerous studies have demonstrated that task-related pupil dilation reflect the 
processing load of a task (Beatty & Lucero-Wagoner, 2000). Thus, pupillary responses “can 
be used to index the extent of central nervous system processing allocated to a task” 
(Granholm & Verney, 2004, p. 2). Increased pupillary responses have been observed in the 
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literature when stimuli are cognitively engaging or emotionally salient. 
In our study, pupil size increased in all conditions of the emotion recognition task after 
an initial constriction caused by the first appearance of a face picture and the corresponding 
change in lighting conditions (see Figure 2). In line with our hypothesis and consistent with a 
recent study by Leknes and colleagues (Leknes, et al., 2012), subsequent pupil (re-) dilation 
was always greater in the OXT than in the PLC group, indicating that improved emotion 
recognition was associated with greater allocation of attentional resources during task 
performance (see Figure 1A). Of note, changes in pupil dilation appeared to be most 
pronounced during the processing of happy expressions. We, thus, suggest that altered 
attentional resource allocation might also underpin the well-established OXT effects 
regarding the promotion of prosocial and approach-related behavior. 
The gender effect of the stimulus material, showing greater pupil dilation for female 
than for male faces, is in line with early pupillometric studies reporting greater pupil dilation 
during the viewing of pleasant and attention-demanding pictures (e.g., Garrett, Harrison, & 
Kelly, 1989; Hess & Polt, 1960; Hess, Seltzer, & Shlien, 1965; Libby, Lacey, & Lacey, 
1973). Hess and Polt (1960), for example, reported that male participants showed greater 
pupil size in response to a picture of partially nude woman, while female participants were 
more interested in pictures of a baby and a partially nude man (see also Garrett, et al., 1989; 
Hess, et al., 1965; Libby, et al., 1973). Although we only used very reduced and simplified 
stimulus material (grayscales, equalized in size and enclosed within an elliptic mask that only 
showed the face itself) and no pictures showing erotic scenes or naked individuals, greater 
pupil dilation for female than for male faces might still indicate male participants’ greater 
interest for female faces. In contrast to the PLC group, pupil dilation in the OXT group did 
not differ between female and male faces; that is, an increase in attentional resource allocation 
affected male even more than female faces and was thus reducing the processing advantage of 
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female faces. 
Notably, pupil diameter in the baseline phase did not differ between the groups. Thus, 
there is no evidence for an altered “exploration mode” of the cognitive system after OXT 
administration (i.e., no evidence for a general enhanced sensitivity of the cognitive system, 
see Aston-Jones & Cohen, 2005; van der Meer, et al., 2010). Van der Meer and colleagues 
(2010), for instance, reported greater pre-experimental baseline pupil diameter in individuals 
with high fluid intelligence as compared to normal controls (i.e., tonic changes in pupil 
diameter). In our study, on the contrary, we only observed task-related differences in pupil 
diameter between the groups (i.e., phasic changes in pupil diameter).  
Gamer and Buchel (2012) recently investigated whether OXT modulates sympathetic 
or parasympathetic activity by measuring skin conductance and heart rate responses during a 
static emotion recognition task. By showing that OXT differentially enhanced the heart rate 
response to emotional expressions but had no impact on skin conductance, the authors 
provided evidence that OXT selectively influences parasympathetic activity. As it has been 
discussed that changes in pupil diameter are mainly due to altered parasympathetic activity 
(Steinhauer, et al., 2004), our findings are in line with this view. 
Limitations 
It should be noted that we only used stimuli with both, an affective and a social 
content (i.e., faces that were developing an emotional expression) and pupil diameter was 
generally increased in all conditions in the OXT group (main effect of group). Therefore, it is 
presently unclear whether OXT also has an impact on pupillary responses during the 
processing of other kinds of stimuli. To elucidate this question, we recommend to use non-
social in addition to socio-affective stimuli in further studies to disentangle affective and 
social aspects of the stimulus material (e.g., by using pictures of faces with emotional and 
neutral expressions or pictures of objects). 
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In our study, the possible impact of the two confounding variables, that is, baseline 
pupil diameter and luminance of the stimulus material, could be excluded. We also controlled 
for differences in participants’ characteristics (e.g., general intelligence, empathy, alexithymia 
and psychopathology) and differences in OXT resorption. However, we did not ask our 
participants about their sexual orientation. Since we argue that differences in pupil diameter 
are associated with differences in interest for the stimulus material in question, sexual 
orientation could be a confound, in particular with regard to the reported gender by group 
interaction. However, the very unlikely case that more homosexual men would have been in 
the OXT than in the PLC group cannot fully explain the pattern of results obtained. A two-
way repeated measure ANOVA with the factors group and emotion, while excluding the 
factor regarding the gender of the stimulus material, still showed a main effect of group on 
pupil dilation [F(1,45) = 4.06, p = .050, partial η2 = .08]. Nevertheless, we recommend to rule 
out this possible confound in further studies when measuring pupillary responses to male and 
female faces. 
It also has to be mentioned that we only investigated the effect of OXT on pupil 
diameter in a sample of male participants. Since there is considerable evidence that OXT 
modulates the neural circuitry involved in face processing in males and females differentially, 
our results might not be generalizable to females. For instance, it has been found that OXT 
decreases amygdala activity in response to aversive threat-related scenes and faces in male 
participants (Domes, Heinrichs, Glascher, et al., 2007; Gamer, Zurowski, & Buchel, 2010; 
Kirsch et al., 2005; Petrovic, Kalisch, Singer, & Dolan, 2008) but increases amygdala 
reactivity to similar stimulus material in female participants (Domes, et al., 2010; Lischke, 
Gamer, et al., 2012). 
Finally, it has to be acknowledged that the size of our effects is rather small, although 
comparable with other studies. Therefore, the present findings should be treated with caution 
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unless replicated in further studies. 
Conclusion 
In conclusion, the finding of increased pupil dilation, in addition to improved 
recognition of emotional expressions after OXT administration, provides evidence for OXT-
induced enhancement of supplemental attentional resources and increased stimulus 
processing. Moreover, our findings of diminished differences in pupil dilation between male 
and female faces after OXT administration demonstrate that OXT increases the salience of 
socio-affective stimuli in general and, in particular, for those stimuli that usually do not 
recruit much attention (i.e., by reducing the processing disadvantage of male faces in male 
participants). Finally, our results are consistent with a recent study by Leknes and colleagues 
(Leknes, et al., 2012) and provide, in addition, first evidence that OXT promotes the 
allocation of attentional resources during elaborate conscious processing of emotional 
expressions in a naturalistic emotion recognition task. 
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Tables 
Table 1 
Intensity levels at which the emotional expressions were correctly recognized and the 
corresponding error rates in the oxytocin and placebo group 
 Intensity levels  Error rates 
 Placebo 
(n = 24) 
 Oxytocin 
(n = 23) 
 Placebo 
(n = 24) 
 Oxytocin 
(n = 23) 
 M SEM  M SEM  M SEM  M SEM 
Happy expressions            
 Male 36.53 1.64  32.83 1.45  0.00 0.00  0.00 0.00 
 Female 34.43 1.99  30.99 1.62  0.01 0.01  0.02 0.01 
Angry expressions            
 Male 43.56 2.37  36.84 1.96  0.07 0.02  0.05 0.02 
 Female 44.21 2.21  35.40 2.36  0.10 0.03  0.16  
Sad expressions            
 Male 53.23 2.22  47.52 2.46  0.20 0.04  0.3 0.04 
 Female 52.27 2.52  48.61 2.62  0.18 0.03  0.1 0.03 
Fearful expressions            
 Male 46.20 1.88  41.06 1.81  0.13 0.03  0.07 0.02 
 Female 45.22 2.17  40.34 1.52  0.06 0.02  0.02 0.01 
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Table 2 
Baseline and task-related pupil diameter in pixels normalized with respect to the camera 
window in the oxytocin and placebo group 
 Baseline pupil diametera  Task-related pupil diameterb 
 Placebo 
(n = 24) 
 Oxytocin 
(n = 23) 
 Placebo 
(n = 24) 
 Oxytocin 
(n = 23) 
 M SEM  M SEM  M SEM  M SEM 
Happy expressions            
 Male 0.21 0.03  0.20 0.06  -0.03 0.01  -0.02 0.01 
 Female 0.21 0.03  0.20 0.06  -0.03 0.01  -0.02 0.01 
Angry expressions            
 Male 0.21 0.030  0.20 0.06  -0.03 0.01  -0.02 0.01 
 Female 0.21 0.028  0.20 0.06  -0.02 0.01  -0.02 0.02 
Sad expressions            
 Male 0.21 0.03  0.20 0.06  -0.03 0.02  -0.02 0.01 
 Female 0.21 0.03  0.20 0.06  -0.02 0.01  -0.02 0.01 
Fearful expressions            
 Male 0.21 0.03  0.20 0.06  -0.03 0.01  -0.02 0.01 
 Female 0.21 0.03  0.20 0.06  -0.02 0.01  -0.02 0.01 
Note. aBaseline pupil diameter was averaged across a 200 ms interval before the presentation of the first picture 
of a set of expressions. bTask-related pupil diameter was averaged across an interval of 800 ms to 3200 ms 
following the presentation of the first picture of a set of expressions. 
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Figures 
 
Figure 1. (A) Intensity levels at which the emotional expressions were correctly recognized 
and (B) task-related pupil diameter averaged across the interval of interest in the oxytocin and 
placebo group as a function of the emotional expression (happy, angry, sad, fearful) and the 
gender (male, female) of the faces. Bars represent mean and standard error of the mean in 
percent or mm. 
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Figure 2. Task-related pupillary responses in the oxytocin and placebo group as (A) a 
function of the emotional expression (happy, angry, sad, fearful) and (B) the gender (male, 
female) of the faces. The interval of interest across which the pupillary responses were 
averaged is highlighted in gray (800-3200 ms following the presentation of the first picture of 
a set of expressions). 
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Abstract 
The neuropeptide oxytocin has been shown to improve many aspects of social 
cognitive functioning, including facial emotion recognition, and to promote social approach 
behavior. In the present study, we investigated the modulatory effects of oxytocin on the 
recognition of briefly presented facial expressions. In order to diversify the degree of visual 
awareness for the facial stimuli, presentation duration was systematically varied. Fifty-six 
participants were administered intranasal oxytocin or placebo in a double-blind, randomized, 
between-subjects design. Participants viewed angry and happy target faces or neutral 
distractors for 18, 35 or 53 ms subsequently masked by neutral faces. Participants had to 
indicate the presence or absence of the briefly presented target face. Discrimination indices 
(d’) showed that oxytocin generally enhanced detection accuracy of emotional stimuli. This 
effect was more pronounced for the recognition of happy faces. We provide evidence that a 
single dose of intranasally administered oxytocin enhances detection of briefly presented 
emotional stimuli. The possible role of stimulus valence and recognition difficulty is 
discussed. 
Keywords: oxytocin, faces, emotion recognition, attention, peptides 
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Introduction 
The neuropeptide oxytocin (OXT) is essential for bonding and attachment in mammals 
(Carter, Grippo, Pournajafi-Nazarloo, Ruscio, & Porges, 2008; Donaldson & Young, 2008) 
and has also been associated with human social behavior (Heinrichs, von Dawans, & Domes, 
2009). In recent years, a number of studies focusing on the cognitive and affective effects of 
OXT have shown that intranasally administered OXT promotes the recognition of emotional 
states (e.g., Di Simplicio, Massey-Chase, Cowen, & Harmer, 2009; Domes, Heinrichs, 
Michel, Berger, & Herpertz, 2007; Guastella et al., 2010), the recollection of social stimuli 
(e.g., Rimmele, Hediger, Heinrichs, & Klaver, 2009) and improves the processing of positive 
social cues and facial expressions in particular (e.g., Di Simplicio, et al., 2009; Gamer & 
Buchel, 2012; Gamer, Zurowski, & Buchel, 2010; Unkelbach, Guastella, & Forgas, 2008). 
Despite these recent advances in characterizing the effects of OXT on the processing 
of socially relevant stimuli such as emotional facial expressions, it is still unclear whether the 
reported effects of OXT are entirely due to modulations in evaluation and appraisal of these 
stimuli (Guastella, Mitchell, & Dadds, 2008) or whether OXT also modulates earlier stages of 
stimulus processing, such as visual attention and awareness (Guastella, Howard, Dadds, 
Mitchell, & Carson, 2009). Thus, in the present study, we used short presentation times of 
emotional stimuli in order to assess the effects of OXT on the recognition of angry and happy 
facial stimuli under conditions of limited awareness. In order to vary the degree of visual 
awareness, equidistant increases of presentation durations were used. We expected that 
intranasally administered OXT would improve the recognition of emotional faces and that the 
effects would extend even to stimuli presented under conditions of limited awareness. 
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Materials and methods 
Participants 
Fifty-six male participants [age: M = 24.18; SD = 3.12] were assigned to receive either 
24 international units (IU) of oxytocin (n = 28; Syntocinon, Novartis, Basel, Switzerland) or 
placebo (PLC; n = 28) within a double-blind, randomized, placebo-controlled study design. 
All participants had normal or corrected-to-normal visual acuity, were free of medication and 
did not report any history of endocrine, neurological or mental disorder. They were instructed 
to abstain from caffeine and nicotine on the day of the study. Smokers (more than 5 cigarettes 
a day) were excluded from participation in the study. 
We planned to investigate a sample of 50 participants, with 25 participants in the OXT 
and 25 participants in the PLC group, to have sufficient power to detect medium-sized 
differences as determined by G-Power 3 (Faul, Erdfelder, Lang, & Buchner, 2007). Six 
additional participants were examined to account for presumed technical difficulties and 
difficulties in substance application.  
The study was approved by the ethics committee of the University of Rostock and was 
carried out at the Department of Psychiatry, University of Rostock, between November 2009 
and January 2010. 
Experimental procedure 
After written informed consent was obtained, participants completed questionnaires on 
depression (Beck Depression Inventory, BDI; Hautzinger, Bailer, Worall, & Keller, 1995), 
(trait) anxiety (State Trait Anxiety Inventory, STAI; Laux, Glanzmann, Schaffner, & 
Spielberger, 1981) and were familiarized with the use of the nasal sprays. Participants self-
administered 3 puffs of OXT or PLC per nostril (each puff with 4 IU), with the PLC 
containing all ingredients except for the peptide. Then all participants underwent a training 
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session to ensure appropriate understanding of the experimental task. Forty-five min after 
substance application, participants answered a multidimensional mood questionnaire 
(Mehrdimensionaler Befindlichkeitsbogen, MDBF; Steyer, Schwenkmezger, Notz, & Eid, 
1997) and started the experiment.  
Randomization of substance allocation procedure was generated by the local 
compounding pharmacist. This sequence was concealed from all persons involved in 
recruitment and testing of the participants. Unblinding was done after completion of testing. 
Experimental task 
The experiment was conducted on a standard computer with a 17” screen with a 
resolution of 800 x 600 pixels and a refresh rate of 170 Hz (confirmed by a photodiode and an 
oscilloscope). Each trial started with a fixation cross (1000 ms) and a short blank screen (100 
ms). Then, an angry, happy or neutral face was presented for 18, 35 or 53 ms, followed by a 
“mask” showing a neutral face (see Figure 1). The initial gaze was fixed to the middle of the 
facial stimulus (between the eyes and the mouth). Participants were explicitly informed that 
two facial stimuli would always appear in each trial, although they might only perceive one. 
Facial stimuli (8 males, 8 females) were taken from the Karolinska Directed Emotional Faces 
database (KDEF; Goeleven, De Raedt, Leyman, & Verschuere, 2008). They were equivalent 
with regard to luminance [F(2,45) = .48, p = .625] and recognizability of the expressed 
emotions [F(2,45) = .95, p = .394]. Two additional neutral faces (1 male, 1 female) were 
selected as mask stimuli and presented in a pseudo-randomized order.  
The experiment contained 288 trials, divided into 8 blocks with 36 trials each. Prior to 
each block, an instruction was given regarding the target emotion in the following trials. In 
each block, 12 angry, happy and neutral facial stimuli were randomly presented with varying 
durations (18, 35, 53 ms). Following each target-mask pair, participants had 3 s to indicate 
whether the target emotion was present or absent (4 blocks angry present/absent and 4 blocks 
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happy present/absent). 
[Insert Figure 1 about here] 
Statistical analyses 
Participants’ performance was analyzed based on signal detection theory. Conditional 
probabilities of hits and false alarms were calculated for each condition and participant. 
Afterwards, individual discrimination indices [d’ = Zhits – Zfalse alarms] and response biases [c = 
-0.5*(Zhits + Zfalse alarms)] were computed and analyzed using separate mixed-design analyses of 
variances (ANOVAs) with the within-subjects factors of face valence (angry, happy) and 
presentation time (18, 35, 53 ms) and the between-subjects factor of group (OXT, PLC). 
Greenhouse-Geisser corrections were applied if the assumption of sphericity was violated and 
significant interactions were followed by simple effects analyses. Analyses were performed 
using SPSS 17 (IBM SPSS Inc., Chicago, IL, USA). The significance level for all tests was p 
< .05. 
Results 
There were no differences with regard to age [t(54) = -.16, p = .870], depression [t(54) 
= -.05, p = .960] and (trait) anxiety [t(54) = -.30, p = .764] between the OXT and PLC group. 
Both groups did not differ on measures of self-reported calmness [t(54) = .32, p = .750], 
wakefulness [t(54) = .45, p =.657] or mood [t(54) = -.94, p = .353] prior to the start of the 
experiment. 
With respect to recognition accuracy (d’), the ANOVA (Group x Valence x Time) 
revealed a significant main effect of group [F(1,54) = 7.93, p = .007, partial η2 = .128], with 
participants who were administered OXT showing enhanced recognition performance for 
emotional faces regardless of valence and presentation time of the target (see Figure 2). 
Appendix C    124 
 
Recognition accuracy increased with longer presentation time of the target stimuli 
[F(1.80,97.17) = 74.09, p < .001, partial η2 = .578]. In addition, a main effect of valence 
[F(1,54) = 150.08, p < .001, partial η2 = .735] illustrated that happy faces were generally 
better recognized than angry faces. A significant interaction of valence and group [F(1,54) = 
4.55, p = .037, partial η2 = .078] was followed by simple effects analyses, which showed that 
the effect of OXT on emotion recognition was more pronounced for happy [F(1,54) = 8.39, p 
= .005, partial η2 = .134] as compared to angry [F(1,54) = 3.21, p =.079, partial η2 = .056] 
faces. Furthermore, we found an interaction of valence and presentation time [F(1.77,19.23) = 
3.75, p =.032, partial η2 = .065], indicating that recognition accuracy increased more rapidly 
for happy than for angry faces with longer presentation times. The interaction of group and 
presentation time was significant at a trend level [F(1.80,97.17) = 2.97, p = .061, partial η2 = 
.052]. Simple effects analyses of presentation time illustrated a stronger effect of prolonged 
presentation on recognition accuracy in the OXT [OXT: F(2,53) = 43.16, p < .001, partial η2 = 
.620] than PLC [F(2,53) = 18.71, p < .001, partial η2 = .414] group. Descriptive results are 
presented in Table S1. 
With respect to response bias (c), i.e., how liberal or conservative participants’ 
responses to the stimuli were, the ANOVA (Group x Valence x Time) revealed more 
conservative responding to longer presentation times of the target stimuli [F(2,108) = 68.16, p 
< .001, partial η2 = .558] and to happy as compared to angry target stimuli [F(1,54) = 24.80, p 
< .001, partial η2 = .315]. Simple effects analyses of the significant interaction of valence and 
presentation time [F(2,108) = 8.25, p <.001, partial η2 = .133] indicated that more 
conservative responding to happy as compared to angry faces was particularly present at 
longer presentation times [18 ms: F(1,54) = 3.13, p = .082, partial η2 = .055; 35 ms: F(1,54) = 
31.71, p < .001, partial η2 = .370; 53 ms: F(1,54) = 24.56, p < .001, partial η2 = .313]. In 
addition, the interaction of presentation time and group was significant [F(2,108) = 5.01, p = 
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.008, partial η2 = .085]. Follow-up analyses showed that the effect of time on response 
behavior was more pronounced in participants who had received OXT [F(2,53) = 35.48, p 
<.001, partial η2 = .572] as compared to PLC [F(2,53) = 24.10, p < .001, partial η2 = .476]. 
However, the response bias did not differ significantly between both groups at individual 
presentation times [all ps >.10]. No further main effects or interactions were significant [all ps 
> .05]. 
[Insert Figure 2 about here] 
Discussion 
The present study provides evidence that OXT enhances detection of very briefly 
presented emotional stimuli, suggesting that OXT modulates awareness of socially relevant 
emotional information in the environment. Thus, OXT presumably modulates even early 
stages of stimulus processing, which suggests that consistently reported improvements in 
facial emotion recognition in previous OXT administration studies (e.g., Di Simplicio, et al., 
2009; Domes, Heinrichs, Michel, et al., 2007; Guastella, et al., 2010) are not exclusively due 
to modulations in evaluation and appraisal of the presented stimuli. In addition, it seems that 
this effect is more pronounced for positive than negative facial stimuli, which is in line with 
previous reports suggesting a particular role of OXT in the processing of positive social 
stimuli (e.g., Di Simplicio, et al., 2009; Unkelbach, et al., 2008). However, it should be noted 
that positive stimuli were more easily recognized in general in the present study. Taking 
stimulus difficulty into account, by comparing recognition of negative and positive emotions 
with equal d’ in the PLC condition (53 ms angry target faces and 18 ms happy target faces), 
the comparable improvement induced by OXT argues against specific interactions with 
emotional valence, suggesting instead that task difficulty may have influenced the pattern of 
results. 
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Apart from the effective restriction of visual presentation necessary for a detailed 
evaluation of the stimuli, our design also limited the potential confounding influence of gaze 
behavior, a factor that was previously found to be modulated by OXT (Guastella, et al., 2008). 
Due to the short presentation times, modulations of overt visual attention are unlikely to be a 
crucial mediating factor in the present study. However, OXT-induced modulations of 
reflexive saccades to the eye region of briefly presented facial stimuli have been reported in a 
recently published study (Gamer, et al., 2010). Consequently, future studies should involve 
eye-tracking in order to further investigate how OXT shapes early stages of visual attention. 
The most likely neural candidate region for the observed effect of OXT on detection of 
emotional stimuli seems to be the amygdala, especially in light of its general role in the 
processing of visual emotional stimuli and studies highlighting the importance of the 
amygdala in detection of briefly presented emotionally relevant stimuli (for a discussion see 
Duncan & Barrett, 2007). Recent neuroimaging findings suggest that the impact of OXT on 
social cognitive behaviour might be a result of its attenuating effects on emotional arousal, 
reflected by reduction of amygdala activity, at least for negative stimuli and in males (Domes 
et al., 2007; Domes et al., 2010; Gamer, et al., 2010; Kirsch et al., 2005). The present results 
may at first seem to be contradictory with these findings. However, enhanced activity for 
dorsal and lateral subregions of the amygdala for happy faces presented for 150 ms was 
reported recently (Gamer, et al., 2010), which might be associated with enhanced emotion 
recognition performance as shown in the present study. Thus, future studies are needed to 
characterize the time course of OXT effects on the behavioral and neural level, ranging from 
stimulus detection to detailed stimulus evaluation and subjective emotional responding. In 
addition, recent results suggest sex-specific modulatory effects of OXT (Domes, et al., 2010). 
Future studies might thus explicitly investigate, if these distinctions translate to different 
modulatory effects in the recognition of emotions in male or female facial stimuli. It might be 
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of further interest to investigate whether the effects of OXT on recognition accuracy are 
specific to emotional or social stimuli, as OXT might enhance visual processing in general, 
for instance by increasing sensitivity towards contrast or spatial frequency. Finally, since 
OXT has been shown to modulate eye gaze even for briefly presented stimuli (Gamer, et al., 
2010), it is an interesting question whether visual attention plays a role in the backward-
masking paradigm. 
To summarize, the present study demonstrates that a single dose of intranasal OXT 
increases detection accuracy for briefly presented emotional faces. This pattern of results, 
combined with the results of previous studies, suggests that OXT might influence both, the 
early stages of stimulus processing and the subsequent conscious evaluation of stimuli on a 
conceptual level. In addition, the results suggest more pronounced OXT effects on detection 
of positive stimuli, although future research should address the possible confounding role of 
valence-specific task difficulty. 
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Figures 
 
Figure 1. Trial structure of the experiment. Participants viewed an instruction cue prior to 
each block. A single trial started with a fixation cross of 1000 ms. Afterwards, an angry, 
happy or neutral face (target/distractor) was presented for 18, 35 or 53 ms and immediately 
followed by a neutral face (mask) for 165 ms. Participants had 3000 ms to indicate the 
absence or presence of the instructed emotion. 
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Figure 2. Effects of intranasal oxytocin on recognition accuracy (d’) for emotional faces as a 
function of emotional valence (angry, happy) and presentation time (18, 35, 53 ms). Bars 
represent mean and standard error of the mean. 
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Supplementary material 
Table 1 
Detection accuracy (d’) and response bias (c) for the detection of angry and happy faces after 
oxytocin or placebo administration 
 Detection accuracy (d’)  Response bias (c) 
 Placebo 
(n = 28) 
 Oxytocin 
(n = 28) 
 Placebo 
(n = 28) 
 Oxytocin 
(n = 28) 
 M SD  M SD  M SD  M SD 
Angry faces            
 18 ms 0.35 0.31  0.34 0.47  0.13 0.44  0.38 0.39 
 35 ms 0.61 0.53  0.81 0.28  0.13 0.33  0.13 0.26 
 53 ms 0.77 0.68  1.08 0.45  -0.05 0.31  0.00 0.31 
Happy faces            
 18 ms 0.85 0.69  1.14 0.44  0.12 0.46  0.12 0.39 
 35 ms 1.30 0.82  1.84 0.61  -0.20 0.40  -0.35 0.47 
 53 ms 1.61 0.90  2.14 0.67  -0.43 0.33  -0.30 0.40 
 
 
